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Myocardial	 infarct	size	 is	clinically	relevant,	affecting	heart	function	and	patient	
prognosis. After myocardial infarction (MI), it is important to establish whether 
myocardial dysfunction is due to permanent infarct damage, or if the myocardium 
is	 viable,	 in	 which	 case	 contraction	 may	 be	 improved	 by	 revascularization.	
Established	 methods	 for	 assessing	 infarct	 size	 and	 viability,	 such	 as	 cardiac	
magnetic resonance imaging with delayed contrast enhancement (DE-CMR) and 
myocardial perfusion imaging are neither readily available nor suitable in acute MI. 
In contrast, electrocardiography (ECG) and echocardiography are widely available 
diagnostic methods at the patient’s bedside at any hour. Echocardiographic strain 
rate imaging, based on measurement of myocardial velocities by tissue Doppler, 
is	a	sensitive	and	objective	method	for	quantification	of	myocardial	contraction.	If	
myocardium contracts, it is viable. Body surface potential mapping (BSPM) records 
ECG	with	multiple	leads	covering	the	entire	thorax,	with	a	variety	of	ECG	variables	
automatically calculated from its recordings. The aim of the studies for this thesis 
was	to	evaluate	whether	infarct	size	and	myocardial	viability	can	be	assessed	by	
strain rate imaging and BSPM.
The studies included up to 62 patients with acute coronary syndrome, most with 
an infarction. BSPM with 123 leads and echocardiography were performed within 
48 hours after onset of chest pain, and repeated during recovery of the infarction, at 
1	to	4	weeks,	and	after	healing,	at	6	to	12	months.	Global	infarct	size	and	segmental	
extent	of	infarct	were	determined	by	DE-CMR	after	healing.
Strain	rate	 imaging	allowed	assessment	of	viability	and	global	 infarct	size	 in	
both	acute	and	chronic	MI.	Strain	mapping	was	validated,	for	the	first	time,	as	a	
semi-quantitative	method	for	the	assessment	of	systolic	strain,	and	showed	excellent	
correlation with quantitative strain values. In chronic MI, segments with systolic 
strain values < -6% were most probably viable, having no infarct or a non-transmural 
infarct. Strain mapping proved as good as quantitative strain in distinguishing 
transmural from non-transmural infarcts. In acute MI, strain- and strain-rate 
variables could distinguish viable from non-viable segments, post-systolic strain 
having the best accuracy at predicting recovery of severe contraction abnormality 
(AUC 0.78).
BSPM	could	estimate	 infarct	size	at	all	stages	of	 the	 infarction,	with	Q-	and	
R-wave variables, as well as the QRS integral having the strongest correlations with 
infarct	size	at	all	 time-points.	The	repolarization	variables	were	clearly	 inferior;	
only in chronic MI did the T-wave variables have nearly as strong correlations with 
infarct	size	as	did	QRS	variables.	In	contrast,	the	repolarization	variables	proved	
good at predicting recovery of left ventricular (LV) function in acute MI, irrespective 
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of MI location. The 1st	QRS	integral	was	the	only	depolarization	variable	good	at	
predicting recovery of LV dysfunction, and the only variable able to estimate infarct 
size	in	addition	to	viability.
In conclusion, strain rate imaging as well as computed ECG variables can predict 
recovery	of	myocardial	 function	in	acute	MI	and	can	assess	 infarct	size	 in	both	
acute and chronic MI. Strain values can be quickly and accurately estimated by the 
strain-mapping	method,	validated	now	for	the	first	time	in	the	assessment	of	infarct	
transmurality. These methods, easily performed at bedside, may help the clinician 
assess	patient	prognosis	and	the	need	for	revascularization	after	MI.
10
1 INTRODUCTION
Myocardial	infarction	(MI)	is	defined	as	cell	death	due	to	myocardial	ischemia,	that	
is,	inadequate	myocardial	blood	flow.	Classical	MI	results	from	plaque	rupture	in	a	
coronary artery leading to an occluding blood clot at the site of the rupture. Heart 
muscle supplied by the occluded artery becomes acutely ischemic, and subsequently 
undergoes necrosis. Myocardial cell death appears initially in the subendocardium, 
the	inner	layer	of	the	left	ventricular	(LV)	wall,	and	from	there,	necrosis	extends	in	a	
wave	front	(Thygesen	et	al.	Third	universal	definition	of	myocardial	infarction	2012).	
After 6 hours of total occlusion, most of the myocardium in the ischemic region is 
infarcted; by 12 to 24 hours, the infarct is fully evolved (Smith et al. 1974, Reimer 
et al. 1977, Jennings & Reimer 1983). The occlusion may, however, be partial or 
intermittent, causing ischemia without necrosis, corresponding to unstable angina 
pectoris in clinical terms. Acute coronary syndrome is the clinical picture resulting 
from classical MI and unstable angina (Bassand et al. Guidelines for the diagnosis 
and treatment of non-ST-segment elevation acute coronary syndromes 2007).
Infarct	size	directly	relates	to	the	occurrence	of	congestive	heart	failure,	ventricular	
arrhythmia, and cardiac death (Roes et al. 2007, Wu et al. 2008, Kwon et al. 2009, 
Larose et al. 2010, Gibbons 2011). Timely reperfusion therapy for acute MI limits 
infarct	size,	and	thus	plays	an	important	part	in	reducing	MI-related	mortality	rates	
(Boersma et al. 1996, 2006). Patients who develop a large infarct need the effective 
medical therapy shown to improve LV function and survival. Regular follow-up is 
also	important	in	these	patients,	who	often	need	resynchronizing	and	defibrillating	
pace-makers for improving symptoms and prognosis; in cases of end-stage heart 
failure, sometimes an option is even cardiac transplantation.
Within a few seconds after acute coronary occlusion, ischemic myocardium 
ceases contracting. If coronary perfusion is restored, either spontaneously or by 
revascularization,	contraction	may	recover,	as	long	as	the	myocardium	is	viable.	In	
a wider sense, viability means the presence of life. Myocardium is most often viable 
and recovers after reperfusion if the infarct scar is limited to the subendocardium. 
Myocardium	with	transmural	 infarct	(50–100%	of	the	myocardial	 thickness)	 is	
unlikely to recover (Choi et al. 2001). Assessment of viability is important, as patients 
with ischemic, viable myocardium have substantially better event-free survival after 
revascularization	than	do	those	receiving	only	medical	therapy.	In	patients	without	
viability,	revascularization	may	do	more	harm	than	good	(Allman	et	al.	2002a,	
Schinkel et al. 2007).
The	infarct	scar	can	be	directly	visualized	by	several	imaging	methods,	namely	
contrast-enhanced cardiac magnetic resonance imaging (DE-CMR), single-photon 
emission computed tomography (SPECT), and positron emission tomography 
11
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(PET).	All	of	these	methods	are	standard	for	assessment	of	infarct	size	and	viability.	
Viability may also be assessed by stress echocardiography. However, none of these 
methods is widely available, they cannot be performed at the bedside, and they 
are seldom suitable in the acute phase of MI. Electrocardiography (ECG) and 
echocardiography, on the other hand, are routinely used for cardiac diagnostics, 
and are easy to perform also in the acute phase, at any time of day. The severity 
and	extent	of	wall-motion	abnormalities	on	two-dimensional	echocardiography	
correlate	with	infarct	size.	LV	ejection	fraction	(EF)	is	a	strong	predictor	of	survival	
after acute MI, and is related to the magnitude of infarcted myocardium (Weir 
& McMurray 2006, Wu et al. 2008, Larose et al. 2010). In acute MI, however, 
contraction	abnormalities	may	overestimate	infarct	size,	because	contraction	may	
improve if the myocardium is viable. Visual ECG analysis can demonstrate the 
presence of an infarct by Q waves, reduced R waves, and inverted T waves, but 
cannot	distinguish	transmural	from	non-transmural	infarcts.	Infarct-size	estimation	
is possible by the Selvester QRS score, but the score is less validated in acute MI, 
and has not served to assess viability (Ideker et al. 1982, Roark et al. 1983, Ward 
et al. 1984a, Engblom et al. 2005b, Geerse et al. 2009, Weir et al. 2010).
Strain rate imaging, introduced in the 1990’s (Fleming et al. 1994), is a new 
echocardiographic	 imaging	mode	 for	 the	quantification	of	 regional	myocardial	
deformation. This technique is based on measuring myocardial velocities by tissue 
Doppler. Strain rate imaging has been validated in ischemia and MI diagnosis. 
Compared	with	visual	wall-motion	analysis,	strain	rate	 imaging	 is	an	objective	
method for the assessment of myocardial contraction and is more sensitive in the 
detection of myocardial contraction abnormalities. Body surface potential mapping 
(BSPM) has been in use since the 1970’s for computed analysis of ECG from 32 to 
264 leads covering the thoracic surface. It has proven more sensitive than traditional 
ECG in the diagnosis of ischemia and infarction. Computed BPSM variables detect 
ECG changes not visible on the standard 12-lead ECG, and some of the best recording 
locations are outside the standard 12 leads. This thesis will discuss the use of strain 
rate	imaging	and	BSPM	in	assessment	of	infarct	size	and	viability.
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2 REVIEW OF THE LITERATURE
2.1 Natural course of myocardial infarction
2.1.1 Evolution of myocardial infarction
Total	occlusion	of	coronary	flow	causes	transmural	ischemia.	As	shown	in	animal	
studies,	within	30	seconds	after	occlusion	of	coronary	flow,	myocardial	contraction	
completely	 ceases	 (Theroux	 et	 al.	 1974).	 After	 20	minutes	 of	 total	 ischemia,	
myocardial cell death occurs, initially in the inner half of the ventricular wall, the 
subendocardium.	From	the	subendocardium,	necrosis	extends	in	a	wave	front:	After	
3	hours	of	occlusion,	salvageable	myocardium	still	exists,	but	after	6	hours,	most	of	
the myocardium in the ischemic region is infarcted. At 24 hours, the infarct is fully 
evolved,	extending	through	the	full	thickness	of	the	ventricular	wall	in	most	of	the	
ischemic region (Smith et al. 1974, Reimer et al. 1977, Jennings & Reimer 1983).
Acute	partial	occlusion	of	a	coronary	artery,	reducing	endocardial	flow	by	only	
10 to 20% of the normal at rest, causes subendocardial ischemia and impaired 
myocardial contraction. The contraction abnormality worsens gradually with 
diminished	flow,	but	contraction	is	not	completely	 lost	until	endocardial	flow	is	
reduced	by	90%	(Vatner	1980).	Moderate,	40%,	reduction	of	myocardial	blood	flow	
for	24	hours	leads	to	significant	infarction,	mainly	in	the	subendocardium,	but	also	
extending	to	the	midmyocardium.	Even	5	hours	of	moderate	ischemia	may	cause	
patchy	subendocardial	necrosis	(Kudej	et	al.	1998).
One week after the acute event, the infarcted myocardium enters the healing 
phase, during which the necrotic myocardium is replaced by a dense collagenous 
scar. When scarring is complete, after 1.5 months or later, the MI is said to be 
healed, or chronic (Alpert et al. 2000).
2.1.2 Clinical significance of myocardial infarct size
After	acute	MI,	MI	size	is	the	major	predictor	of	clinical	outcome.	Infarcts	have	
been	classified	as	small	(<	10%	of	the	LV),	medium	(10–30%	of	the	LV),	and	large	
(> 30% of the LV) (Alpert et al. 2000). In the era before reperfusion therapy, all 
acute	MI	patients	who	died	of	cardiogenic	shock	had	at	autopsy	an	infarct	size	>	
40% of the LV. With the introduction of reperfusion therapy and modern medical 
treatment,	patients	with	MI	size	>	40%	of	the	LV	after	acute	MI	have	been	able	to	
survive for more than a year (McCallister et al. 1993). In a recent CMR study, 80% 
of	the	patients	with	prior	MI	who	died	during	a	5-year	follow-up	had	an	MI	size	>	
13
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10%;	a	cutoff	MI	size	of	24%	had	the	best	accuracy	at	predicting	mortality	(hazard	
ratio 2.1) (Bello et al. 2011).
Both	EF	and	LV	volume	reflect	MI	size	and	are	strong	predictors	of	mortality.	
The 6-month mortality was higher in thrombolysed patients with predischarge EF 
<	40%	than	in	those	with	a	better	EF	(8.6–15.2%	vs.	<	2.2%)	(Volpi	et	al.	1993).	LV	
end-systolic	volume	showed	independent	and	incremental	prognostic	significance	
over	EF:	In	patients	with	EF	<	50%,	5-year	survival	was	significantly	greater	if	end-
systolic	volume	was	below	the	median	than	above	(survival	80–90%	vs.	50–70%)	
(White et al. 1987). Importantly, an even stronger predictor of mortality than EF 
and	LV	volume	was	total	MI	size	as	measured	directly	by	DE-CMR	(Roes	et	al.	
2007).	MI	size	by	CMR	showed	good	correlation	with	EF	and	LV	volumes,	and	
predicted	symptomatic	heart	failure.	In	most	patients	with	MI	size	<	18.5%	of	the	
LV, EF was > 40%, and heart failure rarely occurred (Wu et al. 2008).
2.2 Viability
Viability refers to ischemic, dysfunctional myocardium at least partly alive and having 
the potential to recover after myocardial perfusion is restored, either spontaneously 
or	after	reperfusion	therapy.	The	term	“viability”	usually	signifies	improvement	of	LV	
function	by	revascularization	in	patients	with	chronic,	regional	ischemia	caused	by	
significant	stenosis	in	the	coronary	arteries	supplying	the	dysfunctional	LV	regions	
(Allman 2013). Observational and retrospective studies indicate that patients with 
viability	have	substantially	better	event-free	survival	after	revascularization	than	do	
those receiving medical therapy only (Allman et al. 2002b, Schinkel et al. 2002). 
After	acute	MI,	dysfunctional	myocardium	may	contain	a	mixture	of	the	following:	
myocardium without necrosis, but dysfunctional due to stunning or hibernation; 
partly viable myocardium with subendocardial infarct; non-viable myocardium 
with transmural infarct, associated with irreversible dysfunction. Stunned and 
hibernating myocardium, as well as myocardium with a subendocardial infarct, 
has	 the	 potential	 to	 recover.	Myocardium	 with	 transmural	MI	 (50–100%	 of	
the	myocardial	 thickness)	 is	 less	 likely	to	recover.	The	transmural	extent	of	LV	
myocardial necrosis correlated with grade of permanent LV dysfunction, and was 
a better predictor of functional LV recovery after reperfusion than was total MI 
size	(Choi	et	al.	2001).	After	acute	MI,	recovery	of	contraction	of	reperfused	viable	
myocardium is delayed, requiring days to weeks, even several months (Bourdillon 
et	al.	1989,	Pfisterer	et	al.	1991).
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2.2.1 Stunning
Stunning refers to prolonged, but completely reversible, myocardial dysfunction 
caused by a transient ischemic episode. Importantly, stunned myocardium is 
hypo- or non-contractile, despite the absence of cell death and despite normal 
resting	coronary	flow.	Stunning	was	nicely	demonstrated	by	Heyndrickx	and	co-
workers	(1975)	in	an	experimental	study	in	dogs.	They	showed	that	brief	periods	
of coronary artery occlusion caused prolonged impairment of myocardial function 
despite	normalized	coronary	flow	and	ECG	changes.	After	a	5-minute	occlusion,	
myocardial contraction recovered gradually over 2 to 6 hours; after a longer, 
15-minute	occlusion,	recovery	was	slower,	and	normalization	of	contraction	took	
up to 24 hours. After a 2-hour occlusion, recovery of regional myocardial dysfunction 
could continue up to 4 weeks, even though most of the improvement in contraction 
occurred between 24 hours and one week after reperfusion (Bush et al. 1983).
In patients, stunning is observable after successful reperfusion therapy for 
acute	MI,	after	episodes	of	unstable	angina,	and	after	exercise-induced	ischemia.	
The recovery time for stunned myocardium varies—depending on the severity 
and duration of ischemia—from a few hours to a few weeks. Even dysfunctional 
myocardium with subendocardial infarction may improve contraction if the outer 
layers	of	the	myocardial	wall	are	stunned	(Ellis	et	al.	1983).	The	exact	mechanism	
of	ischemic	injury	leading	to	stunning	is	unknown,	but	this	mechanism	is	associated	
with	rapid	generation	of	oxygen-derived	free	radicals	after	reperfusion,	and	with	
alterations in calcium homeostasis. Importantly, contraction of stunned myocardium 
normalizes	during	catecholamine	infusion,	indicating	that	the	contractile	apparatus	
of	the	myocyte	 is	sufficiently	 intact	to	allow	full	contraction	(Kloner	&	Jennings	
2001).
2.2.2 Hibernation
Hibernating myocardium involves, similarly to stunning, reversibly dysfunctional 
myocardium. In contrast to stunning, hibernation is due to partially reduced 
coronary	flow	distal	 to	 a	 coronary	 artery	 stenosis.	 In	 hibernation,	myocardial	
metabolism is reduced to equal hypoperfusion, with the demand for energy in 
balance with supply in the resting state. Acutely reduced myocardial perfusion 
leads	to	proportionally	decreased	contraction.	Over	the	first	few	hours,	myocardial	
metabolism is also improved, with reduced lactate production and recovery of 
creatine phosphate values. Thus, moderately ischemic myocardium with reduced 
contraction may remain viable for several hours, a phenomenon called short-term 
hibernation (Vatner 1980, Ross 1991, Heusch et al. 2005). Short-term hibernation 
was	demonstrated	 in	dogs	by	Matsuzaki	et	al.	 (1983).	Reduction	of	myocardial	
blood	flow	through	partial	coronary	artery	stenosis	immediately	caused	reduction	
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in systolic wall thickening. When, after 5 hours of ischemia, complete reperfusion 
had	been	established,	wall	thickening	partially	improved	during	the	first	3	days,	
and	completely	normalized	after	7	days	(Matsuzaki	et	al.	1983).	However,	moderate	
ischemia lasting > 5 to 24 hours does lead to subendocardial, and possibly also to 
midmyocardial	infarcts	(Kudej	et	al.	1998).
In chronic hibernation, ischemia persists for days to months. In chronic 
hibernation, myocardial hypoperfusion, a consequence of, rather than the reason 
for	myocardial	dysfunction,	is	initiated	by	a	reduced	coronary	flow	reserve	in	the	
presence of normal resting perfusion. Most often, chronic hibernation is preceded 
by repetitive episodes of stunning. Subsequently, prolonged ischemia initiates 
adaptive metabolic changes in the myocytes, and structural changes also occur, 
including apoptosis. Because of these events, dysfunctional myocardium, after long 
periods of hypoperfusion, may remain viable and recover. Recovery of myocardial 
function	after	revascularization	may,	however,	take	more	than	a	year,	and	due	to	
structural	changes,	myocardium	may	recover	incompletely	(Bax	et	al.	2001,	Canty	
& Fallavollita 2005).
2.3 Infarct size by histopathologic examination
All	 established	non-invasive	 imaging	methods	 for	 assessment	 of	MI	 size	have	
undergone	validation	against	histologically	determined	MI	size	 in	experimental,	
or in anatomic pathologic clinical studies.
Standard	 microscopic	 post-mortem	 examination	 can	 identify	 myocardial	
necrosis 6 to 12 hours after MI onset; gross anatomic changes in the myocardium 
appear after 12 to 24 hours (Cotran et al. 2010). Histochemical stains can delineate 
necrotic myocardium and facilitate macroscopic recognition of the infarct area only 
2	to	3	hours	after	MI	onset.	Staining	of	 tissue	slices	with	 the	 tetrazolium	salts	
nitro	blue	tetrazolium	and	triphenyltetrazolium	chloride	 is	the	gold	standard	in	
assessment	of	infarct	size	acutely.	Tetrazolium	compounds	are	reduced	by	lactate	
dehydrogenase	enzymes	 to	a	red	 formazan	precipitate	 in	normal	myocardium,	
whereas	the	necrotic	myocardium	depleted	of	enzymes	remains	pale	(Vargas	et	
al.	1999).	In	chronic	MI,	the	extent	of	infarct	scar	can	be	directly	evaluated	from	
tissue slices without any need of staining.
2.4 Biomarkers reflecting myocardial injury
Cardiac	biomarkers	have	shown	a	good	correlation	with	MI	size,	and	thus	serve	as	
a	semi-quantitative	measure	of	MI	size.	In	patients	with	acute	MI,	since	the	1970’s,	
cardiac	enzymes	have	been	one	means	of	indirect	MI	size-assessment.	CK-MB,	an	
isoenzyme	of	creatine	kinase	(CK)	found	predominantly	 in	heart	muscle,	 is	 the	
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most	specific	enzymatic	marker	of	myocardial	necrosis,	and	therefore	became	the	
preferred marker over aspartate aminotransferase, lactate dehydrogenase, and CK; 
all	three	of	these	were	the	first	available	diagnostic	markers	of	acute	MI.	Nowadays,	
for	detection	of	myocardial	 injury,	cardiac	 troponin	 is	 the	standard	biomarker,	
because	of	its	being	an	extremely	sensitive,	and	100%	specific,	marker	of	myocardial	
damage	(Thygesen	et	al.	Third	universal	definition	of	myocardial	infarction	2012).
2.4.1 CK and CK-MB
The	 most	 accurate	 methods	 for	 evaluation	 of	 enzymatic	 MI	 size	 in	 patients	
hospitalized	for	acute	MI,	are	based	on	frequent	sampling	of	total	CK	or	CK-MB	
for	several	days.	MI	size	calculated	from	such	complete	enzyme	activity	curves	in	
non-reperfused	patients	has	shown	a	strong	correlation	with	post-mortem	MI	size	
(r = 0.87). The more simple measure of peak CK or peak CK-MB also showed a 
very	good	correlation	with	anatomic	MI	size	(r	=	0.79)	(Hackel	et	al.	1984).	After	
reperfusion, peak CK- and CK-MB values are higher and appear more rapidly, 
because	of	the	wash-out	phenomenon	of	these	cytosolic	enzymes	that	accumulate	
in the myocardial interstitium following coronary vessel occlusion. At similar peak 
CK and CK-MB levels, reperfused patients had smaller MI damage than did patients 
without reperfusion. Rapid appearance of peak CK and CK-MB predicted better 
recovery of myocardial function (Ong et al. 1983, Tamaki et al. 1983, Choi et al. 
2001).	In	reperfused	patients,	the	correlation	between	peak	CK-MB	and	MI	size	
on	CMR	or	SPECT	was	r	=	0.65–0.83.	The	peak	values	performed	almost	as	well	
as	did	cumulative	enzyme	release	(Choi	et	al.	2001,	Hedstrom	et	al.	2007,	Chia	et	
al. 2008, Di Chiara et al. 2010).
2.4.2 Cardiac troponins
Cardiac	troponin	T	(TnT)	and	I	(TnI)	prove	to	be	contractile	proteins	of	the	myofibril,	
and cardiac troponins in the blood are very sensitive markers of myocardial necrosis. 
In patients treated with percutaneous coronary intervention (PCI) for ST-elevation 
MI (STEMI), peak values of troponin as well as of CK-MB appeared 3 to 12 hours 
after	PCI.	Peak	troponin	values	correlated	with	MI	size	as	well	as,	or	better	than	did	
peak	values	of	CK-MB.	The	correlation	of	peak	TnT	and	TnI	with	MI	size	on	CMR	
was	r	=	0.76–0.82,	(Hedstrom	et	al.	2007,	Di	Chiara	et	al.	2010);	the	correlation	was	
r	=	0.45–0.74	with	technetium-99m	SPECT	used	for	measurement	of	MI	size	(Chia	
et al. 2008, Byrne et al. 2010). Troponin values measured as early as 2 hours after 
PCI	showed	good	correlation	with	MI	size	(r	>	0.6).	Prespecified	time-points	had	
comparable	correlations	with	MI	size	to	those	of	peak	values:	The	best	correlations	
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were obtained at 4 hours post PCI for CK-MB (r = 0.63), 24 hours for TnT (r = 
0.66), and 72 hours for TnI (r = 0.73) (Chia et al. 2008).
2.5 Imaging of infarct size and viability – established 
methods
2.5.1 Cardiac magnetic resonance imaging
Cardiac magnetic resonance imaging (CMR) with delayed contrast enhancement 
is regarded as the modern golden standard for non-invasive assessment of MI 
size,	because	it	has	shown	almost	perfect	agreement	with	the	histopathologically	
determined	shape	and	size	of	the	infarct	scar.	Since	the	first	studies	in	explanted	
canine hearts in the early 1980’s (Goldman et al. 1982), DE-CMR has received 
extensive	validation	in	experimental	and	clinical	studies,	for	both	acute	and	chronic	
MI	(Kim	et	al.	2009b,	Perazzolo	Marra	et	al.	2011).	With	its	extremely	high	spatial	
resolution, DE-CMR can detect infarcts as small as 1 gram of myocardium, and 
allows	determination	of	the	transmural	extent	of	MI	(Wu	et	al.	2001a).	In	a	recent	
multicenter trial, its sensitivity in MI detection was as high as 99% in acute, and 
94% in chronic cases. In 97% of the trial’s patients, location of hyperenhancement 
and region perfused by the infarct-related artery matched (Kim et al. 2008). In 
the	acute	phase,	however,	hyperenhancement	overestimates	final	 infarct	size	by	
about	a	third	(Hombach	et	al.	2005,	Baks	et	al.	2006,	Larose	et	al.	2010).	MI-size	
measurements from DE-CMR images have shown low intra- and interobserver 
variability, and high reproducibility (Mahrholdt et al. 2002).
2.5.1.1 Main principles of the CMR technique
CMR relies on special software programs, called pulse sequences, to differentiate 
myocardium from other biological tissues, and to assess myocardial perfusion and 
infarct scar. Cine imaging is the CMR technique used to evaluate cardiac volume, 
mass, and contractile function. T2-weighted imaging reveals myocardial edema 
and is useful in the diagnosis of acute MI. DE-CMR, however, is the best technique 
for	assessment	of	infarct	scar	and	viability.	DE-CMR	uses	an	extracellular	contrast	
agent,	most	commonly	gadolinium,	to	visualize	irreversibly	injured	myocardium.	In	
DE-CMR images, normal myocardium appears black because of rapid gadolinium 
washout, but infarcted regions appear bright or hyperenhanced because of the 
higher concentration and slower washout of gadolinium associated with the greater 
distribution area: In acute MI, membrane rupture occurs and then gadolinium 
diffuses into myocytes; in chronic MI, myocytes are replaced by scar. The amount 
of	hyperenhancement	is	usually	assessed	from	short-axis	images	of	the	heart,	either	
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visually,	or	by	planimetry.	Infarct	size	as	a	percentage	of	the	LV	is	calculated	by	
adding the percentage of hyperenhancement in each of 17 segments, and dividing 
by 17 (Kim et al. 2009a).
2.5.1.2 Infarct size by CMR and prognosis
Infarct	size	determined	by	DE-CMR	has	been	a	strong	predictor	of	clinical	outcome,	
independent	from	LV	EF	and	volume.	Infarct	size	also	predicts	LV	function	and	
adverse remodeling of the LV. (Roes et al. 2007, Wu et al. 2008, Kwon et al. 2009, 
Larose	et	al.	2010).	 In	patients	with	acute	MI,	a	cutoff	MI	size	of	18.5%	had	a	
sensitivity of 88% and a negative predictive value of 96% at predicting mortality, 
re-infarction,	or	heart	failure.	Infarct	size	in	subacute	MI	had	a	good	correlation	
with EF and LV volumes measured 3 months later: r = -0.76 for EF, 0.74 for LV 
end-systolic	volume	index,	and	0.64	for	LV	end-distolic	volume	index.	Patients	with	
an	infarct	size	>	14%	had	reduced	EF	<	50%	at	follow-up;	patients	with	adverse	
remodeling	had	significantly	larger	MI	size	than	had	those	without	(mean	MI	size	
30% vs. 19%) (Wu et al. 2008). Findings indicative of microvascular damage predict 
adverse	LV	remodeling	and	poor	clinical	outcome,	 independently	of	 infarct	size	
(Hombach et al. 2005, Wu et al. 2008).
2.5.1.3 Transmurality of infarct by DE-CMR and segmental viability
Improvement of regional myocardial contraction after reperfusion is related to 
transmurality of infarct scar. In acute MI, myocardial function is very likely to 
recover, if < 25% of the LV wall thickness is hyperenhanced. Some recovery is 
possible with an infarct transmurality of 25 to 75%. If microvascular obstruction is 
evident, recovery is highly unlikely (Choi et al. 2001, Gerber et al. 2002). In chronic 
MI,	dysfunctional	myocardial	segments	with	a	transmural	extent	of	scar	≤	50%	are	
likely	to	recover	after	revascularization.	If	the	transmural	extent	of	infarct	is	51	to	
75%, only about 10% of segments recover, and if > 75%, recovery is unlikely. The 
more dysfunctional but viable the segments, the more EF improves during follow-up 
(Kim et al. 2000, Selvanayagam et al. 2004, Kuhl et al. 2006). Figure 1 shows an 
example	of	an	infarct	scar	including	both	transmural	and	non-transmural	infarct.
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Figure 1. This DE-CMR image shows a heart 6 months after an ST-elevation MI caused by occlusion of the 
proximal LAD which was treated successfully by primary PCI 2 hours after onset of chest pain. The infarct 
appears white, and the viable myocardium, black. Nearly 100% transmural infarction of the mid- and apical 
septum (red arrow). At the apex (yellow arrow), infarct transmurality is 50%, and in the mid-lateral wall the 
infarct is non-transmural, <50% of the wall thickness (green arrow). LAD = left anterior descending coronary 
artery, MI = myocardial infarct, PCI = percutaneous coronary intervention.
2.5.2 Nuclear imaging methods
Single-photon emission computed tomography (SPECT) and positron emission 
tomography (PET) are nuclear imaging methods used for diagnosis of coronary 
artery disease and assessment of viability in patients with LV dysfunction. SPECT 
and	 PET	 both	 show	 good	 sensitivity	 (80–90%)	 for	 detection	 of	 viability,	 but	
specificity	is	lower	(50–60%	for	SPECT,	60–70%	for	PET)	(Schinkel	et	al.	2007).	In	
ischemic cardiomyopathy, recovery of viable but dysfunctional myocardial segments 
after	revascularization	has	been	associated	with	less	adverse	remodeling	of	the	LV,	
improved	exercise	capacity	and	symptoms,	and	better	survival.	An	increase	in	EF	
after	revascularization	is	probable	if	≥	25%	(4	segments)	of	the	LV	is	dysfunctional	
but	viable	 (Bax	et	al.	2005).	Studies	 suggest	 that	viability	on	 imaging	predicts	
improved	survival	after	revascularization	of	patients	with	ischemic	cardiomyopathy	
(Allman et al. 2002b, Beanlands et al. 2007).
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2.5.2.1 SPECT
SPECT uses radioactive tracers, namely thallium-201 and technetium-99m-labeled 
agents, for assessment of myocardial perfusion and viability. Tomographic images 
of the heart come from a gamma camera that detects the uptake of the radioactive 
tracer in myocardium. The activity of the tracer in the LV is then displayed in 
images. Myocardial uptake of the tracer relies on the presence of perfusion, as well 
as cell membrane- and mitochondrial integrity. In areas of myocardial infarct tracer 
activity at rest will be reduced, because uptake of the tracer is dependent on cellular 
viability.	If	the	uptake	is	≥	50%	of	that	in	normal	myocardium,	the	dysfunctional	
myocardium	is	considered	viable;	if	30	to	50%,	the	finding	is	equivocal;	and	if	<	30%,	
the myocardium is considered non-viable. Use of technetium-99m-labeled agents 
also permits assessment of LV function, which may aid in viability detection. SPECT 
after stress permits detection of inducible ischemia, revealing the hemodynamic 
significance	of	coronary	artery	stenosis.	 Inducible	 ischemia	 is	also	a	marker	of	
viability (Beller et al. 1977, Beller 2000, Holly et al. 2010, Beller & Heede 2011).
MI	 size	 by	 SPECT	 closely	 reflects	 histologic	MI	 size,	 and	 shows	 excellent	
correlation	with	MI	size	by	DE-CMR.	 In	acute	MI,	 technetium-99m	sestamibi	
SPECT	can	assess	the	size	of	myocardium	at	risk,	and	final	MI	size	measured	at	
discharge	from	hospital	predicts	mortality:	Patients	with	<	14%	MI	size	on	SPECT	
have	a	low	mortality,	≤	2%,	during	6	to	12	months	of	follow-up	(Prigent	et	al.	1986,	
Wagner et al. 2003, Fieno et al. 2007, Gibbons 2011). Because the spatial resolution 
of	SPECT	is	 lower	 than	that	of	CMR	(10	mm	vs.	1–2	mm),	SPECT	may	fail	 to	
identify subendocardial infarcts < 50% of the wall thickness. Other disadvantages 
of SPECT are radiation burden and attenuation artefacts from the diaphragm and 
from women’s breasts (Wagner et al. 2003, Holly et al. 2010).
2.5.2.2 PET
PET differs from SPECT in that, in addition to myocardial perfusion, it assesses 
myocardial metabolism. Radioactive perfusion tracers used for PET include N-13-
ammonia, Rb-82, and O-15-water; the most usual tracer of metabolism is F-18-
fluorodeoxyglucose	(Ghosh	et	al.	2010).	PET	can	quantify	myocardial	blood	flow	
and, as compared with coronary angiography, PET has high diagnostic accuracy 
in coronary artery disease diagnosis (Di Carli & Hachamovitch 2007). Detection 
of viability is based on active glucose metabolism in myocardium with normal or 
reduced perfusion. Myocardium without metabolism and with severely reduced or 
absent perfusion is non-viable (Ghosh et al. 2010).
MI	size	by	PET	correlates	strongly	with	MI	size	by	CMR,	and	both	methods	are	
accurate in predicting recovery from myocardial dysfunction (Klein et al. 2002, 
Kuhl et al. 2006). The advantage of PET, as compared with SPECT, is its shorter 
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acquisition time, and its better diagnostic accuracy due to the lack of attenuation 
artefacts	and	better	resolution.	PET,	however,	 is	an	expensive,	time-consuming,	
and	complex	method,	and	therefore	is	rare	in	clinical	practice	(Bengel	et	al.	2009).
2.5.3 Echocardiography
2.5.3.1 Basic principles of echocardiography
Echocardiography, or heart ultrasound, is based on transmitting ultrasound with 
a	transducer.	Sound	with	a	wave-frequency	>	20	kHz	is	inaudible,	and	is	therefore	
termed ultrasound. The transmitted ultrasound waves propagate through the 
body,	and	are	reflected	back	by	the	heart	and	other	structures.	The	transducer	
that	transmitted	the	ultrasound	also	receives	these	reflected	echoes.	The	intensity	
of	reflected	ultrasound	depends	on	the	properties	of	 the	tissue,	which	makes	 it	
possible to differentiate between different structures, such as between myocardium 
and	blood.	Reflections	from	structures	further	away	return	later	than	reflections	
closer	to	the	transducer.	Based	on	the	 intensity	of	reflected	ultrasound	and	the	
time	from	transmission	to	reflection,	a	two-dimensional	 image	of	the	heart	can	
be	produced	by	the	ultrasound	machine,	and	also	be	visualized	on	a	screen	in	real	
time. Echocardiography is completely safe for the patient, and can be performed at 
the patient’s bedside because ultrasound machines are easily movable (Otto 2004).
2.5.3.2 Assessment of infarct size by two-dimensional echocardiography
In patients with acute coronary syndrome, ischemia causes myocardial contraction 
abnormalities in the region distal to the occluded coronary artery. These contraction 
abnormalities are, on two-dimensional echocardiography, visible as regionally 
impaired LV wall motion or wall thickening (Schiller et al. 1989a, Lang et al. 
Recommendations	for	chamber	quantification	2006).	The	contraction	abnormality	
is proportional to the severity of ischemia, and accordingly, LV contraction may 
be reduced (hypokinetic) or absent (akinetic or dyskinetic) (Kerber et al. 1975).
Regional contraction abnormality is very sensitive (94%) for diagnosis 
of acute coronary syndrome, and absence of contraction abnormalities is of 
excellent negative predictive value (98%) (Cheitlin et al. 2003). Pioneer studies 
by Nieminen and Heikkilä (1975) showed echocardiography to be a valuable 
imaging tool for non-invasive assessment of MI location and extent in acute 
MI patients, a finding supported subsequently by others (Wyatt et al. 1981, 
Cheitlin et al. 2003). After acute MI, myocardial dysfunction may be reversible 
because of stunning or hibernation, and therefore the extent of myocardial 
dysfunction may not correlate with MI size. If the transmural extent of MI 
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damage is < 50%, myocardial contraction may recover completely. Thus, in the 
chronic phase of MI, subendocardial infarcts may cause no visible contraction 
abnormalities, and the infarct scar may go unnoticed (Mahrholdt et al. 2003).
Experimental studies
Studies in dogs reveal that early after coronary artery occlusion, correlation between 
the	echocardiographic	extent	of	myocardial	dysfunction	and	histological	MI	size	is	
poor;	but	at	48	hours	after	occlusion	it	becomes	significant	(r	=	0.72–0.89)	(Wyatt	
et al. 1981, Nieminen et al. 1982). Contraction abnormalities on echocardiography 
tend to overestimate MI, which may be due to myocardial stunning, tethering of 
normal	segments	adjacent	to	those	infarcted,	or	transient	ischemia	of	myocardium	
adjacent	to	the	infarcted	region.	Indeed,	after	48	hours	of	coronary	occlusion	in	
dogs,	the	transmural	extent	of	infarct	in	dyskinetic	segments	has	ranged	from	21	
to 100%, which is why some dyskinetic segments may show functional recovery 
later (Lieberman et al. 1981).
Clinical studies
Studies have shown that wall-motion abnormalities on two-dimensional 
echocardiography	are	associated	with	MI	size	 in	patients	with	recent	and	with	
old MI. In autopsy studies, the severity of segmental and global LV dysfunction 
on	echocardiography,	performed	within	weeks	before	death,	shows	a	significant	
relationship	with	segmental	and	global	MI	size,	with	all	segments	having	a	transmural	
extent	of	MI	>	75%	as	being	a-	or	dyskinetic.	Importantly,	all	hypokinetic	segments	
have been viable, having no, or subendocardial infarction (Weiss et al. 1981, Shen et 
al. 1991). In the acute phase, within a few days after admission, the echocardiographic 
extent	of	myocardial	dysfunction	has	shown	a	significant	correlation	with	MI	size	
on thallium-201 and technetium-99m stannous pyrophosphate scintigraphy (r = 
0.87	and	0.74,	respectively)	(Nixon	et	al.	1980).
In	 patients	 with	 NSTEMI,	 a	 wall-motion	 score	 (WMS)	 index	 >	 1.3	 could	
differentiate	among	patients	with	substantial	MI	damage,	≥	12%	of	the	LV	by	DE-
CMR, with good accuracy (Eek et al. 2010). In patients with STEMI, WMS could 
differentiate among segments with no, non-transmural, or transmural (> 50% 
of segment thickness on DE-CMR) MI early after thrombolysis, as well as in the 
healing	phase	1	to	2	weeks	later.	A	significant	correlation	existed	between	EF	and	
global	MI	size	by	DE-CMR,	increasing	from	the	early	acute	phase	(r	=	-0.51)	to	the	
healing	phase	(r	=	-0.74)	(Sjoli	et	al.	2009).	After	healing	of	MI,	the	EF	and	WMS	
index	has	shown	significant	correlations	with	global	MI	size	(r	=	0.55–0.71	and	r	=	
0.67–0.76,	respectively),	and	WMS	with	segmental	MI	size	(r	=	0.53)	by	DE-CMR.	
EF	and	WMS	index	could	distinguish	large	MIs	from	medium-size	MIs,	but	could	
not differentiate between medium and small MIs. WMS could separate segments 
with	infarct	transmurality	>	50%	from	those	with	a	lesser	extent	of	MI	(Gjesdal	et	
al. 2008, Thorstensen et al. 2012).
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2.5.3.3 Viability assessment by echocardiography
Myocardial wall thickness
In chronic MI, akinetic, thinned, and hyperechogenic myocardium indicates an 
infarct	scar.	Myocardial	wall-thickness	≤	5	to	6	mm	indicates	transmural	MI	and,	in	
patients	with	chronic	MI,	virtually	excludes	viability.	Dysfunctional	segments	with	
a	wall	thickness	>	6	mm	may	recover	after	revascularization	(Cwajg	et	al.	2000,	La	
Canna et al. 2000, Schinkel et al. 2002). Acute, severe ischemia causes thinning of 
the myocardial wall; without reperfusion, necrotic myocardium will remain thin. 
Thickened, edematous myocardium in the ischemic region after reperfusion therapy 
performed 3 to 6 hours after onset of ischemia indicates transmurally infarcted 
myocardium. If reperfusion is performed earlier, wall thickness remains normal, 
indicating	myocardium	that	is	stunned	or	non-transmurally	infarcted	(Bijnens	&	
Sutherland 2008, Merli et al. 2008).
Dobutamine stress echocardiography
If the myocardium contracts, it is at least partly viable, but akinetic and dyskinetic 
myocardium may also be viable, in acute MI as well as in the chronic phase. Improved 
contraction	of	dysfunctional	myocardium	on	echocardiography	during	exercise	or	
pharmacologic stress is proof of viability. In clinical assessment of viability, the 
stress echo method most widely used is dobutamine stress echocardiography (DSE) 
(Schinkel et al. 2007, Sicari et al. 2008).
In pigs, both acutely ischemic and hibernating dysfunctional myocardium 
have shown a biphasic response to dobutamine: After an initial low dose, an 
initial improvement occurred in myocardial contraction; higher doses, however, 
caused	a	mismatch	between	blood	supply	and	myocardial	demand	because	of	flow-
limiting coronary artery stenosis. Consequently, contraction deteriorated together 
with increased myocardial lactate production and acidosis (Chen et al. 1995). Such 
a biphasic response in patients with chronic ischemic LV dysfunction predicted 
segmental recovery after coronary artery bypass surgery (CABG) in 63% of segments 
at 3 months, and in 75% of segments at 14 months. In patients with a biphasic 
response	 in	≥	4	segments,	global	LV	function	was	 likely	to	 improve	(sensitivity	
89%,	specificity	81%)	(Cornel	et	al.	1998).	In	stunned	myocardium	after	acute	MI,	
contraction has improved to normal during inotropic stimulation, without a biphasic 
response (Mercier et al. 1982).
The value of DSE in predicting functional recovery after CABG in patients with 
chronic LV dysfunction was studied in one pooled analysis including all studies 
available from 1980 to 2007: In predicting recovery of regional myocardial function 
after	revascularization	in	patients	with	chronic	ischemic	LV	dysfunction,	DSE	had	
a	weighted	mean	sensitivity	of	80%,	specificity	of	78%,	positive	predictive	value	
of 75%, and negative predictive value of 83%. The presence of several viable but 
dysfunctional	segments	(≥	2–4)	predicted	recovery	of	global	function.	Viability	by	
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DSE	also	seemed	to	indicate	better	survival	in	revascularized	patients	than	in	those	
not	revascularized,	or	in	those	revascularized	but	without	viability.	In	comparison	
with	SPECT,	PET,	and	CMR,	DSE	showed	a	lower	sensitivity	but	a	higher	specificity	
in predicting recovery of regional and global LV function (Schinkel et al. 2007).
2.5.3.4 Evaluation of prognosis in MI patients by echocardiography
Echocardiography is a useful tool in assessment of prognosis. In patients with acute 
MI,	the	presence,	as	well	as	the	extent	and	severity	of	LV	regional	dysfunction	predict	
clinical	outcome.	In	general,	patients	with	only	mild	and	 localized	wall-motion	
abnormalities show a low risk for complications. In comparison, patients with a 
larger	extent	and	severity	of	wall-motion	abnormality	by	echocardiography	(e.g.	
WMS	index	>	2	and	EF	<	45%)	are	at	increased	risk	for	in-hospital	pump	failure,	
malignant ventricular arrhythmia, and death (Nishimura et al. 1984, Cheitlin et 
al. 2003, Dokainish et al. 2014). EF during healing of MI is a strong predictor of 
6-month	mortality,	compared	with	an	EF	≥	40%,	an	EF	<	40%	being	associated	
with up to seven-fold mortality (Volpi et al. 1993).
2.6 Strain rate imaging in assessment of myocardial 
infarction
2.6.1 Definition of strain and strain rate
Strain is a measure of myocardial deformation, and is calculated as the percentage 
change in length or thickness of a myocardial segment relative to its initial value. 
By	definition,	myocardial	expansion	yields	positive	strain	values,	and	compression,	
negative values. When the heart contracts, the myocardium shortens in the 
longitudinal direction and thickens radially. Thus, longitudinal shortening yields 
negative strain values, and radial thickening, positive strain values. Longitudinal 
lengthening and radial thinning, appearing during diastole and in the case of systolic 
dyskinesia, yield opposite strain values. Strain rate is the velocity of deformation, 
expressed	as	s-1 (D’hooge et al. 2000b).
2.6.2 The technique of tissue Doppler strain rate imaging
Strain rate imaging (SRI) is based on measurement of myocardial velocities by the 
tissue Doppler technique. Doppler echocardiography was initially developed for 
measurement	of	blood	flow	velocities,	but	the	tissue	Doppler	technique	is	basically	
the	same:	Ultrasound	waves	reflected	from	a	moving	surface	will	have	a	frequency	
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different	from	frequencies	transmitted	by	the	transducer,	lower	if	the	reflector	is	
moving away from the transducer, and higher if moving towards the transducer. 
This difference in frequency, termed the Doppler shift, allows determination of the 
velocity	of	the	moving	object. Myocardial velocities can be sampled simultaneously 
at multiple sites and displayed in real-time as color-coded two-dimensional images, 
superimposed on gray-scale images. This is termed color Doppler myocardial 
imaging, or tissue Doppler imaging, and the technique is basically the same as color 
flow-mapping	of	blood-flow	velocities.	For	visualization	of	myocardial	velocities,	
however,	filter	settings	are	adjusted	to	allow	detection	of	 the	 low-velocity-	and	
high-amplitude ultrasound signals typical for myocardium; high-velocity and low-
amplitude	signals	from	normal	blood	flow	are	filtered	out	(McDicken	et	al.	1992,	
Miyatake et al. 1995).
Longitudinally, myocardial velocities are normally highest in the basal parts of 
the	LV,	and	decrease	towards	the	apex.	Radially,	myocardial	velocities	increase	from	
the	epicardium	towards	the	endocardium.	Subsequently,	a	velocity	gradient	exists	
in the myocardial wall. This gradient is the same as strain rate, calculated as the 
difference of local velocities between two points divided by the distance between 
the	points	(spatial	derivation	of	velocities).	Myocardial	strains	are	then	extrapolated	
from the strain-rate data by temporal integration of strain-rate values. Strain and 
strain rate are better measures of regional myocardial contraction than is velocity, 
because myocardial velocities are affected by the overall translational motion of 
the heart as well as by the tethering and traction caused by neighboring segments 
(Fleming	et	al.	1994,	Heimdal	et	al.	1998,	D’hooge	et	al.	2000a,	Derumeaux	et	al.	
2000, Urheim et al. 2000).
Practical issues concerning strain rate imaging
While strain and especially strain rate closely correlate with regional myocardial 
contractility, their values are affected by loading conditions, strains more so than 
strain rates: An increased preload causes an increase, and an increased afterload 
a decrease in these values. At high heart rates, strain values decrease, whereas 
strain rates are unaffected (Urheim et al. 2000, Jamal et al. 2001a, Weidemann 
et al. 2002b).
In the tissue Doppler technique, careful alignment of the ultrasound beam as 
closely parallel as possible to the direction of myocardial movement is important 
to avoid underestimating velocities. Consequently, only longitudinal myocardial 
velocities can be measured from the entire LV by use of apical views; radial 
velocity measurements are limited to the posterior and anteroseptal walls by use 
of parasternal views. In addition to Doppler angle, myocardial velocity signals 
may	be	affected	by	aliasing	and	reverberations,	a	fact	which	should	be	recognized	
(Marwick 2006).
Similar to tissue velocities, strains and strain rates can be displayed as color-coded 
two-dimensional	images	in	real	time.	Positive	strain	values	indicating	expansion	
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(lengthening/thickening) of the myocardium appear in shades of blue; negative 
strain values indicating compression (shortening/thinning) appear in shades of 
yellow	or	red.	For	exact	quantification,	regional	myocardial	strain	rate-	and	strain	
curves	can	be	extracted	from	these	color-coded	maps.	Image	optimization	allows	
high temporal resolution of systolic and diastolic strain and strain rates; even 
isovolumic	pre-	and	post	ejection	strain	rates	are	discernable.
2.6.3 Development of strain rate imaging
Tissue Doppler strain- and strain rate imaging was made possible by the advent 
of a technique for measuring myocardial velocities. The idea that the velocity of 
myocardial	movement	reflects	myocardial	function	led	in	the	early	1990’s	to	the	
development of color Doppler myocardial imaging, also called tissue Doppler 
imaging	(McDicken	et	al.	1992).	Quantification	of	myocardial	velocities	by	this	
technique revealed higher velocities in the endocardium than in the epicardium. 
Use of M-mode color Doppler myocardial imaging allowed calculation of these 
myocardial velocity gradients across the myocardial wall thickness, in effect, identical 
to radial strain rates (Fleming et al. 1994). Software for color Doppler myocardial 
imaging was included in standard ultrasound machines, allowing measurement of 
longitudinal as well as radial myocardial velocities (Wilkenshoff et al. 1998). As an 
extension	of	the	processing	of	tissue	Doppler	data	by	this	software,	the	first	real-
time application for the measurement of strain rates was proposed by Heimdal 
et al. (1998). Based on this SRI method, Urheim et al. measured longitudinal 
myocardial strain as the time integral of regional strain rates, and validated these 
strain	measurements	against	 sonomicrometry	 in	dogs	subjected	 to	myocardial	
ischemia (Urheim et al. 2000).
2.6.4 Strain rate imaging in healthy individuals
Edvardsen et al. (2002) found that in healthy individuals, longitudinal strain- and 
strain-rate values in the LV were homogenous, in contrast to myocardial velocities 
that	decreased	from	base	to	apex.	In	validating	SRI	against	CMR	tissue	tagging,	
they showed that radial and longitudinal strain values, when measured by both 
methods, agreed very closely (Edvardsen et al. 2002). In healthy adults aged 18 to 
76, normal systolic longitudinal average strain rate values have ranged from -0.9 to 
-1.9 1/s. Normal end-systolic longitudinal average strain values have ranged from 
-14% to -24%. Radial strain-rate and strain values are higher than longitudinal 
values, normal systolic radial strain rates > 3.0 1/s and strain > 45%. Normal 
diastolic strain rate values are also higher radially than longitudinally. In children 
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and teenagers, strain and strain rate values are higher than in adults (Kowalski et 
al. 2001, Weidemann et al. 2002a, Sun et al. 2004, Herbots 2006).
The effect of aging and gender on longitudinal strains and strain rates has been 
reported	in	two	studies	of	healthy	adults.	No	significant	changes	in	peak	systolic	
strains or strain rates were evident with aging. Both studies found an age-dependent 
increase in late diastolic strain rates, but only one found an age-dependent decrease 
in early diastolic strain rates. Neither study found a difference in strain rates by 
gender, but one study found strain values to be higher in women (Sun et al. 2004, 
Herbots 2006).
Feasibility of longitudinal SRI has been > 90%, apical segments, especially in 
the anterior and lateral walls, being more often unsuitable for analysis than mid- or 
basal	segments	because	of	difficulties	in	parallel	alignment	of	the	ultrasound	beam	
in apical segments (Kowalski et al. 2001, Sun et al. 2004). Intra- and inter-observer 
variability has been 12 to 15% for longitudinal systolic strains and strain rates, the 
variability being higher for diastolic values (Kowalski et al. 2001, Weidemann et 
al. 2002a, Herbots 2006).
2.6.5 Strain rate imaging in assessment of myocardial ischemic injury
SRI was developed for evaluation of regional myocardial function, SRI allowing 
quantification	of	regional	myocardial	contraction	and	diastolic	function,	as	well	as	
timing	of	mechanical	events.	One	of	the	major	applications	of	SRI	is	diagnosis	of	
myocardial ischemia, because ischemia is the most common cause of LV regional 
contraction	abnormalities.	Ischemia	affects	first	the	endocardium,	the	myocardial	
layer	most	 vulnerable	 to	 ischemic	 damage.	 Because	myocardial	 fibers	 in	 the	
endocardium are oriented longitudinally, the longitudinal strains and strain rates 
are especially suitable for assessment of ischemia. Studies using tissue Doppler show 
that absolute systolic strain- and strain-rate values decrease, or become inverted, 
in	ischemic	myocardium,	while	the	values	in	adjacent,	non-ischemic	myocardium	
remain unaffected.
2.6.5.1 Experimental studies
Consequences of acute ischemia for myocardial strains and strain rates
Experimental	validation	studies	in	animals	have	compared	systolic	tissue	Doppler	
strain- and strain-rate values to myocardial contraction measured by ultrasonic 
crystals implanted in the myocardial wall. LAD occlusion for two minutes in dogs 
causes longitudinal lengthening of ischemic segments, as revealed by positive 
longitudinal systolic strain- and strain-rate values. The same values remain negative 
in non-ischemic segments that retain normal contraction (Urheim et al. 2000). 
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Moderate	 hypoperfusion	 (50%	 reduction	 of	myocardial	 blood	 flow)	 results	 in	
reduced longitudinal systolic shortening and strain values, whereas total occlusion 
causes systolic lengthening and inverted, positive systolic strain values. Both grades 
of acute ischemia cause post-systolic shortening and strain (Skulstad et al. 2006a). In 
response to LAD occlusion, radial thickening ceases, and radial strain rates decrease 
nearly	to	zero,	while	non-ischemic,	normally	contracting	segments	retain	normal	
positive	radial	strain	rates	(Derumeaux	et	al.	2000).
In	closed-chest	pigs	subjected	to	acute	ischemia,	typical	changes	in	radial	strains	
and strain rates occur. Brief LCX occlusion for 20 seconds has led to a marked 
decrease in radial end-systolic strain values in the ischemic myocardium. Onset of 
myocardial	thickening,	as	defined	by	the	appearance	of	a	positive	strain	value	during	
systole,	was	significantly	delayed,	and	thickening	continued	after	aortic	valve	closure	
(post-systolic thickening). In early diastole, acute total ischemia made peak negative 
strain- and strain rate values fall, but left late diastolic values during atrial contraction 
unaffected.	Severe	hypoperfusion	(≤	20	ml/min)	of	the	LCX	resulted	in	reduced	
end-systolic and early diastolic strain and strain rates, but the values remained 
greater	than	during	total	occlusion	of	coronary	flow.	Hypoperfusion	needed	to	be	
less	severe	(≤	40	ml/min)	to	produce	post-systolic	strain	(Jamal	et	al.	2001).
Strain rate imaging distinguishing viable from non-viable myocardium
In animal studies, SRI has been able to distinguish hypoperfused from stunned 
myocardium, as well as stunning and non-transmural infarction from transmural 
infarction.	In	acute	as	well	as	in	chronic	MI,	a	significant	correlation	appears	between	
radial systolic strain- and strain-rate values with infarct transmurality, lower values 
being	associated	with	a	higher	transmural	extent	of	the	infarct	(Derumeaux	et	al.	
2001, Weidemann et al. 2003).
In chronic MI, response to dobutamine stress echocardiography could 
distinguish segments with non-transmural from those with transmural MI; radial 
strain rates increased with low-dose dobutamine in non-transmural MI, but failed 
to do so in transmural MI. Further, the amount of post-systolic strain increased 
with dobutamine in non-transmurally infarcted segments, whereas systolic strain 
values in non-transmurally as well as in transmurally infarcted segments remained 
reduced (Weidemann et al. 2003).
Early after reperfusion in pigs, stunned segments without infarct have shown 
significantly	 greater	 radial	 strain-rate	 values	 in	both	 systole	 and	diastole	 than	
did segments with transmural infarct. Systolic strain values were equally low 
in stunned and in transmurally infarcted segments, but post-systolic strain was 
greater in stunned segments and was a sign of viability. Further, end-diastolic strain 
(coinciding with atrial contraction) was higher in stunned segments, indicating 
preserved compliance, whereas the lower values in infarcted segments indicated 
increased stiffness (Pislaru et al. 2004b). In stunned segments, following reperfusion 
of total occlusion, longitudinal post-systolic strain values increased (became more 
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negative), whereas inverted, positive systolic strain values decreased, both being 
signs of active contraction; in transmurally infarcted segments, no post-systolic 
shortening was evident (Lyseggen et al. 2005). Post-ischemic stunned segments 
could	also	be	identified	by	their	response	to	dobutamine	stress;	radial	systolic	strain-	
and	strain-rate	values	increased	significantly,	and	post-systolic	strain	disappeared	
(Jamal et al. 2001b). In contrast, with dobutamine challenge, in persistently ischemic 
dysfunctional myocardium, radial systolic strain values decreased, and post-systolic 
strain values increased. Systolic strain rates remained lower than normal without 
any	significant	response	to	dobutamine	(Jamal	et	al.	2001a).
2.6.5.2 Clinical studies
Strain rate imaging in diagnosis of ischemia and infarction
Early clinical studies validated SRI against standard visual two-dimensional gray-
scale wall-motion analysis. In patients with chronic MI, systolic longitudinal strain- 
and strain-rate values have deteriorated with worsening wall-motion abnormality. 
Values of normokinetic segments in MI patients did not differ from those in healthy 
controls (Voigt et al. 2000). Moreover, in patients with recent acute MI, longitudinal 
strain- and strain-rate values were reduced according to degree of wall-motion 
abnormality. Values of normokinetic segments did not differ from those of controls, 
except	 in	the	presence	of	significant	coronary	artery	stenosis,	 in	which	case	the	
values were reduced (Jamal et al. 2002). When SRI was validated against CMR 
tissue tagging in patients with recent acute MI, agreement was good between the 
methods, and both showed reduced or inverted longitudinal strain values in infarcted 
segments,	while	remote	uninjured	segments	showed	strain	values	similar	to	those	
in healthy controls (Edvardsen et al. 2001).
In patients with stable angina pectoris undergoing angioplasty, acute ischemia 
during coronary artery occlusion causes a reduction in both longitudinal and radial 
strain values, and this occurs, according to baseline visual wall-motion analysis, in 
normokinetic segments as well as in those with hypo- or akinesia. The amount of 
post-systolic strain increased during ischemia, and was even more accurate in the 
detection of acute ischemia than was end-systolic strain (sensitivity 95% vs. 86% 
and	specificity	89%	vs.	83%).	Strain	values	returned	to	baseline	immediately	after	
occlusion. Strain analysis appeared more sensitive than visual wall-motion analysis 
in detection of ischemia-related contraction abnormality, especially of dyskinesia 
(Edvardsen et al. 2001, Kukulski et al. 2003).
Validation of strain rate imaging in MI patients against DE-CMR
SRI in the longitudinal direction has been validated against DE-CMR for assessment 
of	the	presence,	segmental	transmurality,	and	total	size	of	MI.	In	all	phases	of	MI,	
systolic	strains	and	strain	rates	were	significantly	less	negative	in	segments	with	
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infarct	than	in	those	without,	in	acute	MI	patients	even	before	revascularization.	
After	PCI	for	acute	MI,	systolic	strain	and	strain	rates	remained	significantly	lower	
in segments with transmural MI than in others at all time-points (Zhang et al. 
2005, Weidemann et al. 2006a, Vartdal et al. 2007). In the subacute phase, peak 
systolic SR > -0.6 1/s could distinguish transmural MI with a sensitivity of 95% 
and	a	specificity	of	91%,	whereas	visual	wall-motion	scoring	could	not.	At	5	months	
after	the	acute	event,	systolic	strains	and	strain	rates	were	significantly	less	negative	
in segments with transmural than in those with non-transmural MI, as well as less 
negative in segments with non-transmural vs. those without infarct (Weidemann et 
al. 2006a). In other studies, this distinction was already possible with good accuracy 
in subacute MI and early after PCI in acute MI (Zhang et al. 2005, Vartdal et al. 
2007).	Early	after	PCI	for	acute	MI,	the	correlation	between	segmental	infarct	size	
and	peak	systolic	strain	was	r	=	0.67;	the	correlation	between	total	infarct	size	and	
averaged systolic strain rates in the infarct region was r = 0.81. It was, in the entire 
LV (global strain) r = 0.77 (Vartdal et al. 2007). The correlation between total infarct 
size	and	global	strain	was	similar	in	chronic	MI:	r	=	0.75	(Sachdev	et	al.	2006).
2.7 Standard 12-lead ECG in the estimation of myocardial 
infarct
2.7.1 Pathologic Q waves
Extent of MI according to Q-wave status
Q waves have long served as indicators of permanent MI damage. The clinical value 
of classifying MIs according to Q waves has intrigued many researchers for years. 
Historically, pathologic Q waves have been regarded as indicators of a transmural 
infarct.	This	conception	has,	however,	been	rejected.	Several	anatomic-pathologic	
studies have consistently reported that both subendocardial and transmural infarcts 
may develop with or without a Q wave. Q wave was, however, more probable in 
infarcts	with	a	transmural	extent	of	50	to	100%	than	in	subendocardial	 infarcts	
(Cook et al. 1958a, Cook et al. 1958b, Savage et al. 1977, Raunio et al. 1979).
Clinical studies using CMR have shown that Q waves are associated more with 
total	size	and	subendocardial	extent	of	the	infarct	than	with	transmurality.	One-third	
or more of patients with subendocardial infarction show Q waves. On the other hand, 
the	absence	of	Q	waves	does	not	exclude	transmural	 infarction.	Subendocardial	
and	transmural	MIs	frequently	co-exist,	one	possible	explanation	for	the	limited	
advantage of Q waves in evaluation of transmurality. As the subendocardial portion 
of	the	myocardium	is	depolarized	during	the	early	parts	of	the	QRS	complex,	Q	
waves	are	more	likely	in	a	subendocardial	infarct	of	large	endocardial	extent	than	in	
a	transmural	MI	of	limited	endocardial	extent	(Wu	et	al.	2001a,	Moon	et	al.	2004,	
Kaandorp	et	al.	2005,	Engblom	et	al.	2007).	In	accordance	with	these	findings,	
31
Review of the literature
several	studies	have	shown	greater	enzymatic	MI	size	in	STEMI	with	Q	waves	than	
in STEMI without Q waves, irrespective of reperfusion therapy (Bar et al. 1987, 
Huey et al. 1987, Isselbacher et al. 1996, Armstrong et al. 2009). The number of Q 
waves	was	associated	with	greater	enzymatic	MI	size	in	post-procedural	ECG	after	
primary PCI for STEMI (van der Vleuten et al. 2009); in patients with NSTEMI, 
as	well,	the	development	of	new	Q	waves	was	associated	with	greater	enzymatic	
MI	size	(Alexander	et	al.	2003).
LV function and viability according to Q-wave status
Q-wave MI (QMI) in patients with STEMI has been associated with greater 
impairment of LV function than that from non-Q-wave MI (NQMI) (Huey et al. 
1987,	Isselbacher	et	al.	1996,	Nijveldt	et	al.	2009).	In	virtually	all	patients	with	QMI	
in the acute phase after thrombolysis LV dysfunction was detectable, but in only 
69%	of	patients	with	NQMI;	moreover,	NQMI	was	associated	with	a	smaller	extent	
of wall-motion abnormality than was QMI (Isselbacher et al. 1996). In patients 
with subacute or chronic MI, EF was lower in QMIs (47%) than in NQMIs (55%); 
however,	when	infarct	location	was	considered,	the	difference	was	significant	only	
in anterior MIs, not in inferior MIs (Moon et al. 2004). Studies using metabolic 
imaging	have	shown	that	the	majority	of	patients	with	LV	dysfunction	associated	
with chronic QMI have viable myocardium, even though viability is more common in 
LV regions without Q waves, and more abundant in patients after NQMI (Schinkel 
et al. 2002, Yang et al. 2004). Importantly, Q waves in the acute phase did not 
exclude	the	presence	of	salvageable	myocardium,	even	though	patients	presenting	
with	STEMI	without	Q	waves	had	smaller	enzymatic	MI	size	(Bar	et	al.	1987).	In	
accordance, recovery of LV dysfunction after thrombolysis for STEMI was greater in 
NQMI	than	in	QMI,	despite	a	similar	extent	of	LV	dysfunction	acutely	(Isselbacher	
et al. 1996).
Prognosis according to Q-wave status
Baseline Q waves in the ischemic region predict worse clinical outcome in patients 
that undergo reperfusion for STEMI. Such patients with QMI had a greater incidence 
of in-hospital congestive heart failure, and higher 30- and 90-day mortality rates 
than did those with NQMI; however, their one-year mortalities did not differ (Aguirre 
et al. 1995, Wong et al. 2006, Armstrong et al. 2009). Number of Q waves has 
predicted late survival: STEMI patients with > 4 Q waves after primary PCI in the 
leads with ST elevation on admission had clearly the highest one-year mortality (van 
der Vleuten et al. 2009). Similarly, in patients with NSTEMI, development of new 
Q	waves	was	associated	with	a	higher	30-day	and	6-month	mortality	(Alexander	
et al. 2003).
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2.7.2 R- and S waves
It has generally been accepted that a decrease in the R wave together with the 
development	 of	 a	 Q	 wave	 reflects	 myocardial	 necrosis.	 Mid-	 and	 late	 QRS	
abnormalities	would	be	expected	in	MIs	affecting	the	lateral	and	basal	parts	of	the	
LV, as these locations of the heart are the last activated. The criteria for R waves, 
R	to	S	ratio,	and	S	waves	in	the	Selvester	score,	have	proven	of	significant	value	
for	estimating	posterolateral	MI	size	(Ward	et	al.	1984b,	Sevilla	et	al.	1990,	Pahlm	
et al. 1998). Evidence is that 8 to 10% of MIs involve only the base of the LV and 
produce no initial QRS changes (Selvester et al. 2011a).
After	experimental	LAD	occlusion,	the	sum	of	R-	and	S	waves	in	ischemia-related	
leads decreases gradually for up to 6 hours after occlusion, more rapidly during the 
first	few	hours	(Smith	et	al.	1974).	In	patients	with	first-time	urgently	reperfused	
STEMI, the amount of increase in the sum of R waves in the infarct-related leads 
from 1 week to 4 weeks after the acute event correlated with the increase in EF and 
with the amount of salvageable myocardium as assessed by scintigraphy (Isobe et 
al. 2006).
In patients with STEMI, ST elevation, together with terminal distortion of the 
QRS	complex,	 indicates	severe,	grade	III	 ischemia	and	predicts	 larger	final	MI	
size.	Grade	III	ischemia	causes	the	disappearance	of	S	waves	in	leads	that	usually	
have	an	rS	configuration	(V1-V3),	and	causes	a	J	point/R	wave	ratio	≥	0.5	in	leads	
usually	having	a	qR	configuration	(Birnbaum,	Drew	2003).
2.7.3 Selvester QRS score
The Selvester QRS score method for assessment of MI size and location
Of	all	scores	for	electrocardiographic	estimation	of	MI	size,	 the	most	validated,	
and also the best performing, is the Selvester QRS score (Pahlm et al. 1998). This 
score was developed by means of a computer model simulating heart activation 
that	showed,	in	each	of	the	12	standard	ECG	leads,	the	extent	of	QRS	change	to	
be	proportional	to	the	extent	of	simulated	MI.	Based	on	the	observations	in	the	
computer simulation, a 54-criteria, 32-point scoring system was developed for 
estimation	of	MI	size;	the	greater	the	score,	the	larger	the	infarct.	In	this	scoring	
system,	each	criteria	has	a	specificity	of	95%	or	greater	 in	normal	subjects,	and	
each point represents 3% of total LV mass. The score is thus capable of indicating 
MI	in	96%	of	the	LV.	A	simplified	37-criterion,	29-point	scoring	system	with	equal	
specificity	can	indicate	MI	in	only	87%	of	the	LV,	with	relative	under-representation	
of posterolateral and basal regions (Wagner et al. 1982, Hindman et al. 1985, 
Selvester	et	al.	1985a).	For	10	of	the	12	standard	ECG	leads	(excluding	leads	III	
and aVR), the QRS score considers Q- and R-wave amplitudes and durations, and 
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S-wave amplitudes, as well as R/Q- and R/S ratios (Selvester et al. 1985b, Selvester 
et al. 2011b).
Histopathologic studies validating the Selvester QRS score
Originally in the pre-reperfusion era, the QRS score was validated in postmortem 
anatomic studies (Ideker et al. 1982, Roark et al. 1983, Ward et al. 1984a). Correlations 
between	 the	simplified	37-criteria,	29-point	QRS	score	and	histopathologically	
determined	MI	size	at	different	locations	was	r	=	0.80	for	anterior,	r	=	0.74	for	
inferior, and r = 0.72 for posterolateral MIs. Use of the complete 54-criteria, 32-point 
QRS score improved the correlation for anterior MIs (r = 0.89), but for inferior 
and posterolateral MIs, the correlations were similar. The QRS score showed only 
a	weak	correlation	with	MI	size	if	the	infarct	involved	multiple	locations	(r	=	0.36).	
(Pahlm et al. 1998).
Clinical studies validating the Selvester QRS score
 
Estimating LV function and enzymatic MI size after acute MI by the Selvester QRS score
The earliest clinical validation studies compared the QRS score with LV EF and 
enzyme	release	after	acute	MI,	in	nonreperfused	as	well	as	in	reperfused	patients.	
In nonreperfused patients, the QRS score measured in the subacute phase showed 
good	correlation	with	early	EF	(r	=	-0.71),	extent	of	LV	dyssynergy	(r	=	0.60),	and	
enzymatic	MI	size	(r	=	0.65–0.72).	In	the	late	acute	phase,	within	3	days	after	the	
acute event, these correlations were clearly weaker (Seino et al. 1983, Hindman et 
al. 1986, Grande et al. 1987). Correlations after reperfusion among studies have 
varied widely. At best, the correlation between QRS score at 1 to 4 weeks and 
enzymatic	MI	size	has	been	r	=	0.57	to	0.75,	and	between	QRS	score	and	EF,	r	
= -0.58 to -0.76 (Juergens et al. 1996, Tateishi et al. 1997, De Sutter et al. 1999). 
In other studies, correlations after reperfusion have been weaker (Timmis 1987, 
Christian et al. 1991). In many studies, correlations of the QRS scores with EF and 
enzymatic	MI	size	have	been	stronger	in	anterior	than	in	inferior	MI.
Association between Selvester QRS score and MI size by myocardial perfusion imaging
Perfusion imaging studies using 201-thallium or 99m-technetium sestamibi have 
shown	significant	correlations	between	Selvester	QRS	score	and	MI	size.	In	the	
subacute phase after thrombolysis for STEMI, the correlation was r = 0.58 to 0.79 
(Juergens et al. 1996, Barbagelata et al. 2005). In patients with residual ST elevation 
after	anterior	MI,	QRS	score	has	shown	no	correlation	with	MI	size	(Adler	et	al.	
2000).	In	the	healing	phase	of	MI,	the	correlation	between	QRS	score	and	MI	size	
was r = 0.70 (De Sutter et al. 1999). In the chronic phase, the correlation between 
QRS	score	and	MI	size	was	r	=	0.55,	unaffected	by	thrombolytic	therapy	(Marcassa	
et al. 2001).
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Association between Selvester QRS score and MI size by DE-CMR
Studies in which DE-CMR imaging was performed simultaneously with the 
recording	of	12-lead	ECG	at	various	phases	of	 infarction	have	found	significant	
correlations	between	Selvester	QRS	score	and	MI	size,	and	good	agreement	for	
MI	localization;	in	the	subacute	phase	after	primary	PCI	for	STEMI,	correlations	
were r = 0.56 to 0.79 (Engblom et al. 2005a, Geerse et al. 2009, Weir et al. 2010); 
after healing of the MI, at 3 to 6 months, they were = 0.41 to 0.78, being slightly 
higher or the same in serial measurements (Bang et al. 2008, Geerse et al. 2009, 
Weir	et	al.	2010,	Carlsen	et	al.	2012).	In	one	study,	the	late	acute-phase	(1–2	days)	
correlation was also measured, which was r = 0.39 (Bang et al. 2008). The local 
QRS score (at one week) correlated with MI transmurality, and the global QRS score 
was	significantly	higher	in	transmural	than	in	non-transmural	MIs,	whereas	the	
presence of Q waves was not indicative of transmural MI (Engblom et al. 2005b).
Estimation of prognosis by Selvester QRS score
MI	size	estimated	by	Selvester	QRS	score	has	correlated	with	clinical	outcomes.	
Two large studies assessed the prognostic value of pre-discharge QRS score in 
patients after reperfusion for STEMI. In one study including 4,000 patients treated 
with primary PCI, 90-day mortality and rate of the composite outcome including 
congestive heart failure, shock, or death increased with increasing QRS scores, being 
lowest	in	patients	with	QRS	score	≤	3,	and	highest	in	patients	with	QRS	score	≥	8	
(mortality	1.9%	vs.	4.9%,	and	composite	outcome	4.5%	vs.	12.1%)	(Tjandrawidjaja	
et al. 2010). In a study including 1,800 patients treated with thrombolysis, both 30-
day and 1-year mortality were lower in patients with a QRS score < 10 than in those 
with	a	QRS	score	≥	10	(1-year	mortality	5.4%	vs.	12.6%)	(Barbagelata	et	al.	2004).	
In	1,900	medically	 treated	patients	with	angiographically	confirmed	significant	
coronary artery disease, 1-year and 5-year mortality increased with increasing QRS 
scores.	At	the	extremes,	QRS	score	0	vs.	QRS	score	≥	10,	1-year	mortality	was	5%	
vs. 9%, and 5-year mortality was 12% vs. 48% (Bounous et al. 1988).
2.7.4 ST segment and T waves
In patients with acute coronary syndrome (ACS), different changes in the 
repolarization	phase	in	the	12-lead	ECG	on	admission	confer	different	prognoses.	
Patients with a negative T wave only, show the lowest incidence of adverse clinical 
outcomes (Savonitto et al. 1999 and 2005). Patients presenting with ST-segment 
depression alone have lower early mortality than do those presenting with ST-
segment elevation. By 30 days, however, the rate of mortality in NSTEMI and STEMI 
equalizes,	and	by	6	months,	adverse	events	are	even	more	frequent	in	patients	with	
NSTEMI than in patients with STEMI (Savonitto et al. 1999, Chan et al. 2009).
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2.7.4.1 ST segment and T wave in STEMI
Assessment of MI size and prognosis by ST-segment- and T-wave changes before 
reperfusion in STEMI
Persistent ST-elevations in patients with ACS indicate transmural myocardial 
ischemia caused by total thrombotic occlusion of the culprit coronary artery. In 
order	to	limit	MI	size,	such	patients	are	treated	with	immediate	reperfusion	therapy,	
either	by	thrombolysis	or	primary	PCI.	Final	MI	size	depends	on	extent	and	duration	
of ischemia before reperfusion.
Time	from	onset	of	occlusion	can	be	approximated	from	the	initial	12-lead	ECG.	
High T waves (> 98th percentile) in leads with ST elevation in the presenting ECG 
indicate earlier time to treatment, and are associated with better clinical outcome 
after	thrombolysis.	Maximum	T-wave	amplitude	has	been	a	stronger	predictor	of	30-
day and 1-year mortality than other ECG-related variables at presentation (Hochrein 
et al. 1998). Early presentation at thrombolysis by the Anderson-Wilkins score—
which, in the presence of ST elevation, considers the number of leads with positive 
T	waves	with	and	without	Q	waves—predicts	smaller	final	MI	size	as	estimated	by	
the Selvester QRS score (Johanson et al. 2005).
Extent	of	ischemia	as	assessed	by	the	number	of	leads	with	ST	elevation	has	
been associated with short- and long-term mortality. Patients with small myocardial 
injury,	having	ST	elevations	in	only	2	to	3	leads,	had	the	best	prognosis,	a	prognosis	
unaffected	by	thrombolysis.	Patients	with	large	myocardial	injury,	with	ST	elevations	
in	≥	6	leads,	had	the	worst	in-hospital	and	10-year	prognosis;	this	was	significantly	
reduced if they had received thrombolysis (Mauri et al. 2002). A higher sum of ST 
elevation	predicted	higher	in-hospital	mortality,	higher	release	of	α-hydroxybutyrate	
dehydrogenase, and lower EF, indicating greater MI damage in patients with a larger 
extent	of	ischemia	(Willems	et	al.	1990).	In	these	studies,	anterior	ST	depressions	
associated with inferior STEMI were considered to be posterior ST elevations, 
and inferior ST depressions associated with anterior STEMI were considered to 
be superior ST elevations. One angiographic study revealed that reciprocal inferior 
ST depressions in patients with anterior ST elevations indicate LAD as the culprit 
artery, and predict higher peak CK level and lower EF than is the case when anterior 
ST elevations are associated with inferior ST elevations; in the latter case the culprit 
artery is most often RCA (Sadanandan et al. 2003).
36
Review of the literature
Assessment of MI size and prognosis by ST-segment and T-wave changes after 
reperfusion in STEMI
Incomplete	ST-segment	normalization	and	residual	ST-segment	elevation	after	
reperfusion	 therapy	 is	associated	with	more	extensive	myocardial	damage	and	
higher mortality, and are better in predicting adverse prognosis than is the initial 
extent	of	ST	elevation	before	reperfusion.
After	 thrombolysis,	 complete	 (≥	 70%)	ST-segment	 resolution	 (STR)	 of	 the	
summed ST elevation at baseline has predicted the lowest short-term mortality, 
and	was	associated	with	the	smallest	MI	size	by	peak	CK	and	the	Selvester	QRS	
score;	patients	with	partial	(30–70%)	STR	had	greater	MI	size	than	did	those	with	
complete STR, and clinical outcome was worst in patients with no (< 30%) STR. 
Analysis of the ST segment at 3 hours vs. 1 hour after thrombolysis has yielded 
similar results (Schroder et al. 1995, Johanson et al. 2009).
STR	extent	showed	similar	prognostic	value	also	after	successful	primary	PCI.	
As compared to no STR, partial or complete STR within 4 hours after successful 
primary	PCI	predicted	smaller	enzymatic	MI	size	and	better	LV	function.	Short-	
and long-term survival was the best in patients with complete STR, and somewhat 
better in those with partial vs. no STR (van ‘t Hof et al. 1997, Brodie et al. 2005, 
De	Luca	et	al.	2008).	The	relationship	between	MI	size	and	extent	of	STR	was	also	
evident in one CMR study (Hallen et al. 2010). Measurement of ST resolution may 
be	done	from	maximal	single-lead	ST	elevation	or	the	sum	of	ST	elevation	pre-PCI.	
Use	of	maximal	residual	ST-segment	elevation	after	PCI	is	easier,	and	showed	a	
strong prognostic value similar to that of STR, and it correlated even better with 
MI	size.	Maximal	residual	ST-segment	elevation	>	2	mm	predicted	larger	MI	size	
and higher in-hospital, 30-day, and late mortality than those of patients with lower 
residual	ST-segment	elevation;	patients	with	≤	1	mm	residual	ST-segment	elevation	
had	the	smallest	MI	size	and	the	lowest	mortality	(McLaughlin	et	al.	2004,	Brodie	
et al. 2005, De Luca et al. 2008, Hallen et al. 2010). Deferring the ECG assessment 
to 24 hours after primary PCI strengthened the correlations between residual ST 
elevation	and	MI	size	by	CMR	(Weaver	et	al.	2011).	Evaluation	of	ST	depression	in	
addition to ST elevation after primary PCI gives incremental prognostic information 
(De	Luca	et	al.	2008,	Tjandrawidjaja	et	al.	2010).	Maximal	residual	single-lead	ST	
deviation at 3 hours post primary PCI (either ST elevation or -depression) was the 
best	predictor	of	enzymatic	MI	size	and	EF,	as	well	as	of	cumulative	mortality	up	
to one year (De Luca et al. 2008).
In STEMI patients treated with successful primary PCI, changes in the ST 
segment	after	reperfusion	therapy	reflect	myocardial	flow	rather	than	epicardial	
flow,	since	almost	half	the	patients	failed	to	show	complete	STR	despite	restoration	of	
flow	in	the	culprit	artery	(van	‘t	Hof	et	al.	1997).	Residual	ST-segment	elevation	has	
been	an	independent	predictor	of	microvascular	injury,	as	determined	by	evidence	
of	microvascular	obstruction	on	CMR.	Residual	ST	elevation	≥	1.5	mm	has	been	
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associated	with	evidence	of	microvascular	obstruction	on	CMR	(Nijveldt	et	al.	2009,	
Weaver et al. 2011).
Negative T waves after reperfusion are associated with better clinical outcome. In 
infarct-related leads, 24 hours after thrombolysis for STEMI, prominent negative T 
waves	(≤	-1	mm)	indicate	viability:	CK	release	was	lower,	recovery	of	LV	dysfunction	
was better, and subsequently EF was higher at discharge and at 1 month than in 
patients without early prominent negative T waves. Negative T waves also showed 
themselves to be markers of patency of the infarct-related artery. Patients without 
early T-wave inversion more often had in-hospital re-infarction and higher in-
hospital	mortality	(Matetzky	et	al.	1994,	Corbalan	et	al.	1999).	After	thrombolysis	
for	STEMI,	prominent	negative	T	waves	(≤	-1.5	mm)	at	hospital	discharge	have	
predicted lower 30-day mortality. In that study, the association between negative 
T waves and patency of the culprit artery was not very strong, which could indicate 
that	 inverted	T	waves	a	 few	days	after	the	acute	event	are	a	reflection	of	better	
microvascular perfusion (Sgarbossa et al. 2000). However, T-wave inversions before 
reperfusion	in	STEMI	patients	have	been	associated	with	worse	coronary	flow	and	
clinical outcome (Huang et al. 2013).
2.7.4.2 ST segment and T wave in Non-ST-segment elevation ACS
In	patients	with	ACS	without	STEMI,	an	ST	deviation	≥	0.5	mm	(depression,	or	
ST elevation < 1 mm) in at least 2 contiguous leads in the acute 12-lead ECG is 
an independent indicator of worse short- and long-term prognosis. Patients with 
isolated T-wave inversions, or no ECG changes, have clearly a more favorable 
outcome.	The	first	studies	demonstrating	the	prognostic	utility	of	ST	deviations	in	
ACS without persistent ST elevations were conducted in the mid 1980’s (Schechtman 
et al. 1989). Later, when ACS treatment included more aggressive anti-thrombotic 
medications and invasive management, several large studies still showed similar 
results (Cannon et al. 1997, Kaul et al. 2001, Savonitto et al. 2005, Yan et al. 2010).
The	presence,	degree,	and	extent	of	ST	depression	at	admission	have	been	
associated with clinical outcome. Compared with patients showing T-wave 
inversions	only,	patients	with	ST	depression	1	to	2	mm	vs.	≥	2	mm	had	a	4-fold	vs.	a	
6-fold higher one-year mortality. Mortality was even higher, if deep ST depressions 
occurred	in	multiple	ECG	regions.	The	sum	of	ST	depression	in	11	leads	(excluding	
aVR) showed a continuous and an incremental correlation with 30-day mortality, 
and a composite outcome of 30-day mortality and MI (Kaul et al. 2001, Savonitto 
et al 2005). Risk assessment may improve by the recording of a follow-up ECG 12 
to 24 hours after admission. Persistent or de-novo ST depression on such a follow-
up ECG have shown an elevated risk for MI and and a two-fold risk of early as well 
as late mortality.
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Several clinical factors associated with adverse prognosis were more prevalent in 
NSTE ACS patients with persistent ST deviations than in those without, including 
older age, prior congestive heart failure, hypertension, and diabetes (Yan et al. 
2010). Irrespective of these clinical factors, ST deviations are independent predictors 
of	prognosis.	Importantly,	 the	presence,	extent,	and	degree	of	ST	deviations	are	
associated with a higher prevalence of three-vessel disease and left main coronary 
disease (Cannon et al. 1997, Savonitto et al. 2005, Yan et al. 2010). The magnitude of 
ST depression was also related to the amount of CK release (Savonitto et al. 2005).
2.7.4.3 ST segment and T wave in chronic MI
After acute MI, evolving changes in ST segments and T waves are associated with 
viability and clinical outcome. Persistent ST elevations after anterior MI have been 
associated with clinically more severe infarction (Mills et al. 1975). In one autopsy 
series,	≥	1	year	after	anterior	MI,	persistently	negative	T	waves	in	leads	with	Q	waves	
indicated transmural MI, and positive T waves non-transmural MI, suggesting that 
in chronic MI, negative T waves are associated with less non-viable myocardium 
(Maeda et al. 1996). In subsequent clinical studies, positive inversion of negative 
T waves from the acute to chronic phase of MI was, as compared to persistently 
negative	T	waves,	associated	with	smaller	enzymatic	MI	size,	significantly	better	
recovery from LV dysfunction, higher EF, less unfavorable remodeling of the LV, 
fewer adverse events, and lower mortality (Bosimini et al. 2000, Sakata et al. 2001, 
Lancellotti et al. 2002).
A	few	CMR	studies	have	reported	on	the	relationship	between	MI	size	and	the	
ST segment and the T wave. The sum of T-wave amplitude at 3 months after STEMI 
in	two	adjacent	leads	with	the	greatest	ST	elevation	on	admission	showed	a	positive	
correlation with EF, irrespective of MI location, and showed a negative correlation 
with	MI	size	by	CMR	in	inferior	MI	(Meijs	et	al.	2011).	Patients	with	ST	elevation	
>	1	mm	in	any	of	leads	V2	to	V5	after	prior	anterior	MI	had	a	significantly	larger	
MI	scar	on	CMR	than	did	those	with	ST	elevation	≤	1	mm	(Tibrewala	et	al.	2007).
2.8 Body surface potential mapping in assessment of  
myocardial infarction
Patients may develop a large MI even in the absence of changes in the acute 12-
lead ECG (Kontos et al. 2001). As the standard chest leads do not directly overlie 
the right ventricle or the posterolateral region of the LV, ECG diagnostic sensitivity 
may	be	enhanced	by	extended	right	and	posterior	leads	(Schmitt	et	al.	2001),	and	
further by the use of BSPM.
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2.8.1 The BSPM method
BSPM is a method of measuring the direction and amplitude of electrical 
potentials at different points in the heart cycle on the entire thoracic surface. BSPM 
measurements may involve different numbers of ECG leads and layouts. Complete 
sampling systems comprise 64 to 242 leads covering both the front and back of the 
thorax.	BSPM	data	require	computed	analysis	(Lux	2011).	The	main	advantage	of	
BSPM in comparison with 12-lead ECG is its spatial resolution. BSPM is a more 
accurate	method	for	diagnosing	and	localizing	the	site	of	both	acute	and	chronic	
MI,	having	better	sensitivity	than	and	similar	specificity	as	the	12-lead	ECG	(Mirvis	
1987, Kornreich et al. 1993, Murray, Alpert 1994, Vesterinen 2007, Ornato et al. 
2009, Daly et al. 2012). Further, computed analysis of BSPM offers the possibility 
to quantify regional electrical function and to measure complicated ECG variables 
such	as	time-voltage	integrals	from	different	de-	and	repolarization	intervals.
2.8.2 BSPM in localizing region of myocardial ischemic injury
In	 dogs,	MI	 size	 after	 occlusion	 of	 the	 LAD	 could	 be	 estimated	 by	 epicardial	
potentials:	Development	of	Q	waves	and	loss	of	R	waves	correlated	with	MI	size,	
and was predicted by amount of ST elevation (Hillis et al. 1976). These changes 
in	epicardial	potentials	are	closely	reflected	in	potentials	on	the	body	surface,	as	
demonstrated	in	one	experimental	study	(Muller	et	al.	1975).	Localized	ST	changes	
on the BSP map indicate the anatomic region of acute ischemia better than does the 
12-lead ECG (Spekhorst et al. 1990, Shenasa et al. 1993, Kornreich 1998, Horacek 
&Wagner	2002).	Location	of	Q	waves	on	the	body	surface	can	localize	an	LV	infarct	
scar in its chronic phase (Hayashi et al. 1980, Ohta et al. 1981 and 1982, Toyama 
et al. 1982).
2.8.3 Precordial mapping in assessment of MI size
The	 first	 clinical	 studies	 attempting	 to	 estimate	 MI	 size	 used	 precordial	
electrocardiographic mapping, with leads covering the region of the heart on the 
chest. These studies were done in patients with non-reperfused, acute anterior MI. 
In precordial mapping, the number of leads with ST elevation > 1.5 mm predicted 
the perfusion defect on scintigraphy (r = 0.56) in the early as well as late acute phase 
of anterior MI (Murray et al. 1979). The sum of ST elevation was found to correlate 
with	enzymatic	MI	size	(r	=	0.55)	(Herlitz	et	al.	1984).	At	24	hours	after	admission,	
the	sum	of	Q-wave	voltages	showed	a	strong	correlation	with	enzymatic	MI	size	
(r = 0.92), unlike the number of leads with Q waves (Vachova et al. 1979); in the 
subacute	phase,	however,	the	number	of	leads	with	pathologic	Q	waves	(≥	0.04s)	
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showed a strong correlation with EF (r = -0.87), with segmental dyssynergy in LV 
cineangiograms,	with	stroke	work	index	(r	=	-0.79),	and	with	cardiac	index	(r	=	
-0.66). Patients having the highest number of Q waves had the poorest prognosis; 
60%	died	shortly	after	the	MI	(Awan	et	al.	1977).	This	finding	was	confirmed	by	
Herliz	et	al.	(1984),	who	showed	in	179	patients,	at	4	days	after	the	acute	event,	a	
strong	correlation	between	number	of	Q	waves	and	enzymatically	determined	MI	
size	(r	=	0.66).	The	sum	of	Q-wave	and	of	R-wave	voltages	both	showed	a	significant	
correlation as well, albeit slightly lower.
2.8.4 Complete BSPM in assessment of MI size
As precordial mapping is suitable mainly for assessment of anterior MI, BSPM with 
more	leads	covering	both	the	front	and	back	of	the	thorax	is	useful	in	assessment	
of MI also involving locations other than the anterior.
Sum of Q- and R waves
The	size	of	old	anterior	and	inferior	MI	has	been	assessed	by	BSPM	of	Q-	and	R	
waves.	The	number	of	leads	with	a	Q	wave	was	greater	with	more	extensive	and	
severe LV dyssynergy, and it correlated inversely with EF by ventriculography in both 
anterior (r = -0.47) and inferoposterior (r = -0.63) MI, and correlated with amount 
of viable myocardium on thallium-201 scintigraphy in anterior MI (r = -0.69). The 
sum of R-wave voltages showed a positive correlation with EF (r = 0.51) and with 
amount of viable myocardium (r = 0.50) in anterior MI, but not in inferoposterior 
MI (Hayashi et al. 1980). A recent study found that a larger number of Q waves 
was	associated	with	a	greater	extent	of	infarct	scar	on	CMR.	However,	number	of	
Q waves in anterior and inferior MIs was not comparable; because—independent 
of	MI	size—anterior	MIs	caused	fewer	Q	waves	in	a	small	localized	precordial	area,	
whereas	Q	waves	in	inferior	MIs	covered	a	larger	area	confined	to	the	inferior	part	
of	the	front	and	back	of	the	thorax	(Bodi	et	al.	2006).	In	anterior	MI,	the	sum	of	
R-wave amplitudes correlated positively with EF and viability (Hayashi et al. 1980). 
The sum of R-wave amplitudes as well as R-wave areas correlated negatively with 
LV dyssynergy (De Ambroggi et al. 1982).
Departure maps 
In MI patients, departure maps display the thoracic area of amplitudes and integrals 
differing more than 2 SD from those of healthy controls: This is called the departure 
area.	Departure	maps	determine	the	location	and	size	of	MI.	In	patients	with	anterior	
MI not treated with reperfusion therapy, the departure area (of amplitudes yielding 
the	largest	departure	area	at	a	time-point	30–60	ms	after	onset	of	QRS)	showed	a	
significant	correlation	with	enzymatic	MI	size	(r	=	0.57)	and	EF	(-0.47)	at	1	week.	
At 1 month, correlation with EF was strong (r=-0.72), and also with the perfusion-
41
Review of the literature
defect area in Thallium-201 SPECT (r = 0.69) (Cahyadi et al. 1989). In patients 
with prior MI, Tonooka et al. (1983a) found a strong correlation between departure 
areas of negative QRS isointegral values and defect score on Thallium-201 SPECT 
in both anterior (r = 0.88) and inferior (r = 0.79) MI; this performed better than 
the	number	of	leads	with	Q	waves.	Similar	findings	emerged	in	correlation	of	QRS	
isointegral departure areas with LV asynergy and EF in ventriculography (Kubota et 
al. 1985). In patients with prior anterior MI, in addition to QRS isointegral departure 
area, the QRST isointegral departure area also showed a similar strong correlation 
with EF (r = -0.90 and -0.84 respectively). The departure area of the QRS amplitude 
at	30	ms,	and	the	number	of	leads	with	Q	waves	showed	significant,	but	weaker	
correlations (r = -0.73 and -0.72) (Hayashi et al. 1993). Departure maps of QRS 
integrals were able to distinguish among MI locations, whereas isopotential maps 
of QRS integrals were consistent only in anterior MIs (Tonooka et al. 1983a).
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3 AIMS OF THE STUDY
The aim of this thesis was to evaluate the use of strain rate imaging and computed 
single-lead	BSPM	variables	in	the	assessment	of	infarct	size	and	viability	in	patients	
with MI. These echocardiographic and electrocardiographic methods are practical, 
and are easily performed even at the bedside, unlike methods such as DE-CMR and 
SPECT.	The	specific	aims	of	the	studies	for	this	thesis	were	the	following:
1. Validation of strain mapping, a semi-quantitative method for estimation of 
systolic	strain	values,	in	assessment	of	the	extent	of	infarct.
2.	 Evaluation	of	systolic	strain	in	assessment	of	the	transmural	extent	of	an	infarct	
and	global	infarct	size	in	chronic	MI	with	DE-CMR	as	the	reference.
3. Evaluation of strain- and strain-rate variables in assessment of viability and in 
predicting recovery from severe contraction abnormality in acute MI.
4.	 Discovery	of	the	best	BSPM	variables	and	the	best	recording	sites	on	the	thorax	
for predicting recovery of LV function with respect to the region of contraction 
abnormality in patients with acute MI.
5.	 Examination	of	which	BSPM	variables	correlate	with	infarct	size	at	different	
stages	of	MI,	from	acute	to	chronic,	and	which	sites	on	the	thorax	yield	the	
strongest correlations.
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4 MATERIALS AND METHODS
4.1 Patients
4.1.1 Recruitment of patients
During 2003 to 2005, patients admitted to the Coronary Care Unit of Helsinki 
University Central Hospital for suspected acute coronary syndrome were screened 
during	office	hours.	Study	inclusion	criteria	were	prolonged	chest	pain	≥	20	minutes	
within 48 hours of recruitment, associated with evidence of acute ischemia: Either 
ischemic changes in the initial 12-lead ECG (ST-segment elevation, -depression, 
or	T-wave	 inversions	 in	≥	2	contiguous	 leads),	or	elevated	cardiac	biomarkers	
indicating myocardial infarction (CK-MBm > 7 µg/l or TnT > 0.03 µg/l), or both. 
Exclusion	criteria	were	bundle	branch	block,	atrial	fibrillation,	pacemaker,	or	need	
for	ventilatory	support.	 In	all,	79	patients	 fulfilled	these	criteria,	and	agreed	to	
participate in the study. Baseline characteristics of the patients are shown in Table 
1.	Study	III	utilized	previously	recorded	BSPM	data	from	73	healthy	controls.	The	
controls	were	matched	by	age,	sex,	and	body	size.
Table 1. Baseline characteristics. 
Baseline characteristics Study I Study II Study III Study IV
Patients, n (male) 26 (21) 23 (18) 62 (48) 57 (45)
Age, years 61 ± 10 60 ± 10 60 ± 11 60 ± 10
Body mass index, kg/m² 27 ± 5 28 ± 5 27 ± 4 27 ± 4
Previous MI in clinical history, n 5 3 10 8
Hypertension, n 11 10 23 23
Peak CK-MBm (μg/L) 170 ± 144 148  ± 145 147 ± 160 137 ± 163
STEMI, n 19 16 48 41
QMI, n 16 13 24 20
PCI 17 16 46 51
CABG 5 4 9 5
Thrombolysis only 4 3 6 2
Culprit artery, n
LAD 15 12 34 33
LCX 2 4 12 8
RCA 9 7 16 16
Data presented as number (n) or mean ± SD. CABG, coronary artery by-pass grafting; LAD, left anterior 
descending coronary artery; LCX, left circumflex coronary artery; MI, myocardial infarction; PCI, percutaneous 
coronary intervention; QMI, Q-wave MI; RCA, right coronary artery; STEMI, ST-elevation MI.
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4.1.2 Ethical aspects
All patients gave their written informed consent. The study was approved by the 
ethics committee of the Helsinki University Central Hospital and complies with 
the Declaration of Helsinki.
4.1.3 Study protocol
The	patients	were	examined	at	three	time-points:	in	the	acute	phase	at	inclusion;	
during	the	healing	phase,	7	to	30	days	later;	and	finally	after	complete	healing	of	the	
infarct,	≥	6	months	from	inclusion.	None	of	the	patients	suffered	from	new	ischemic	
events	between	examinations.	Standard	two-dimensional	echocardiography—with	
or without color tissue Doppler imaging—and in addition, BSPM were performed at 
all three time-points. Patients were imaged with DE-CMR close to the time of their 
last follow-up. The studies presented in this thesis were based on the following data:
Study	I:	SRI-	and	DE-CMR	data	from	the	final	follow-up	(8	± 1 months after 
the acute event).
Study II: SRI data from the acute phase (17 ± 14 hours after onset of chest pain); 
SRI	data	from	the	final	follow-up	(8	±	2	months	after	the	acute	event).
Study III: BSPM- and echocardiographic data from the acute phase (11 ± 11 
hours	after	the	acute	event);	echocardiographic	data	from	the	final	follow-up	(11	±	
4 months after the acute event).
Study IV: BSPM data from the acute phase (10.7 ± 14.4 hours after onset of 
chest	pain),	during	recovery	(at	16	±	14	days),	and	from	the	final	follow-up	(11	±	4	
months	after	the	acute	event),	and	DE-CMR	data	from	the	final	follow-up.
4.2 Echocardiography
4.2.1 Standard two-dimensional echocardiography
Echocardiographic images were acquired by a Vivid 5 or Vivid 7 ultrasound scanner 
(GE	Medical	Systems)	by	using	a	1.5	to	4.0	MHz	phased	array	transducer	(M3S).	
We	analyzed	LV	contraction	real-time	from	two-dimensional	B-mode	images,	in	
all	standard	parasternal	short	axis	views	(basal,	mid-,	and	apical),	and	long	axis	
views	(2-,	3-,	and	4-chamber	views).	The	16-segment	model	of	the	LV	defined	by	the	
American Society of Echocardiography and the American Heart Association served 
for analysis of regional myocardial function (Schiller et al. 1989b, Cerqueira et al. 
2002). Segmental wall motion and wall thickening was assessed visually as normal 
or abnormal. For Studies I and II, each segment was assigned a wall-motion score 
(WMS) from 1 to 4 according to recommendations (1, normokinesia, 2, hypokinesia, 
3,	akinesia,	4,	dyskinesia).	Global	LV	systolic	function	was	quantified	by	ejection	
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fraction calculated by the Simpson rule from apical two- and four-chamber views 
(Lang	et	al.	Recommendations	for	chamber	quantification	2006).
4.2.2 Tissue Doppler strain- and strain rate imaging
Acquisition and analysis of color tissue Doppler data
For Studies I and II, color tissue Doppler loops were recorded by the Vivid 7 
ultrasound	scanner	(GE	Medical	Systems),	and	analyzed	off-line	on	a	personal	
computer that used EchoPAC software provided by GE. Tissue Doppler images 
came from standard apical views (2-, 3-, and 4-chamber views) by limiting the 
imaging sector (sector angle 30°) to one LV wall at a time. The tissue-velocity scale 
was	adjusted	to	avoid	aliasing	(pulse	repetition	frequency	1.0–1.5	kHz).	The	frame	
rate was 209 ± 17 frames per second. Patients were asked to hold their breath if that 
was necessary in order to position the myocardial wall at the center of the imaging 
sector during three consecutive heartbeats. Care was taken to align the ultrasound 
beam to be as parallel as possible to the myocardial wall. Segments in which the 
angle	between	the	beam	and	the	myocardial	wall	exceeded	30°	were	excluded	from	
analysis, as were segments with artefacts or bad image quality.
For	analysis,	the	LV	was	divided	into	16	segments	according	to	the	model	defined	
by	the	American	Heart	Association,	modified	by	the	addition	of	apical	anteroseptal	
and inferolateral segments in Study II (Cerqueira et al. 2002). Strain- and strain rate 
curves came from color tissue Doppler data by placing the sample volume (strain 
length	12	mm)	in	the	middle	of	each	segment.	Manual	adjustments,	if	necessary,	
assured that sample volume was continuously retained within the myocardium. 
The curves of three consecutive heartbeats were averaged for analysis. End-systole 
definition	was	aortic	valve	closure	(timed	at	the	end	of	systolic	flow	through	the	
aortic valve by continuous-wave Doppler).
Strain- and strain rate measurements
Of the strain-curve values obtained, end-systolic strain (SES) and post-systolic strain 
(SPSS), SPSS was	defined	as	the	peak	negative	strain	value	occurring	after	aortic-valve	
closure. The strain rate curves provided the peak negative strain rate value in systole 
(SRS), and the peak positive values during early diastole (SRE) and late diastole 
(SRA). Global SES, SRS, SRE, and SRA values were calculated as the average of each 
patient’s	segmental	values	from	the	16	LV	segments	as	defined	by	the	American	
Heart Association (Cerqueira et al. 2002).
Studies I and II measured SES	from	the	final	recording	(6–12	months	from	the	
acute event). In addition, for Study II, all strain- and strain-rate analyses came 
from the acute recording.
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Strain mapping
With tissue Doppler loops, myocardial strain values can be displayed as two-
dimensional color-coded images which we call strain maps. In these strain maps, 
longitudinal shortening is coded in red, and lengthening in blue. Reduced or absent 
shortening	is	coded	in	gray	(Figure	2).The	transition	from	red	to	gray	can	be	adjusted	
by	means	of	various	strain	scales.	In	Study	I,	we	analyzed	the	strain	maps	by	two	
different strain scales: Strain values > -7% or > -12% were coded in gray on the 
scales ±15% and ±30%, respectively (Figure 3). These two strain scales allowed 
estimation of segmental strain, and each LV segment was accorded a strain-mapping 
score (SMS) from 1 to 4 (Table 2).
Global SMS calculation meant averaging each patient’s segmental SMS by total 
number	of	LV	segments	analyzed,	based	on	the	16-segment	model	defined	by	AHA/
ASE (Cerqueira et al. 2002).
Figure 2. Strain map of the septum. Longitudinal systolic strain is coded in color: Blue represents dyskinesia 
(positive strain values); gray, absent or reduced contraction; red, normal or partly preserved contraction.
Strain mapping 
  Analysis of 2D color-coded strain images 
Septum 
Apical segment 
Mid segment 
Basal segment 
dyskinesia 
reduced 
contraction 
normal or 
partly preserved  
contraction  
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Figure 3. Strain mapping of longitudinal systolic strain values. Blue represents positive strain (myocardial 
lengthening, dyskinesia). The range of strain values represented by gray and red depend on the strain scale 
used; red always means better, or more negative strain, than does gray. Here, the range of strain values 
represented by gray and red are shown for strain scales ± 30% and ± 15%. In the upper image, using the 
strain scale ± 30%, red in the basal segment means normal contraction (strain < -12%); gray in the mid-
segment means reduced contraction ( strain values 0 to - 12%). Using the strain scale ± 15%, we can further 
determine whether contraction in the mid-segment is mildly (strain < -6%) or severely (strain > -6%) reduced. 
In the lower image, changing the scale to ± 15% shows red in the mid-segment (strain < -6%). Hence, the 
contraction there is only mildly reduced (strain values -6 to -12%).
Table 2. Strain-mapping (SM) scores and corresponding range of longitudinal systolic strain values. 
SM score Strain values Myocardial contraction
1 < - 12 % Normal
2 - 6 to -12 % Hypokinetic
3 0 to - 6 % Akinetic/ severely hypokinetic
4 > 0 % Dyskinetic
Estimation of segmental systolic strain is by the strain-mapping method in Figure 3. SM score 1 indicates normal, 
or near-normal segmental contraction. Higher SM scores mean increasingly reduced segmental contraction.
Systolic strain values by strain mapping 
Strain scale ±30% 
Strain scale ±15% 
Range of strain values  
defined by the strain scale  
± 30% ± 15% 
> 0% > 0% 
 0 to -12% 0 to -6% 
< -12% < -6% 
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4.3 Cardiac magnetic resonance imaging
Cardiac magnetic resonance imaging performed in a 1.5 T scanner (Sonata, Siemens 
Medical	Solutions)	served	as	the	reference	technique	for	determining	MI	size	and	
location (Fieno et al. 2000, Wu et al. 2001b, Kuhl et al. 2003).
DE-CMR	was	performed	10	to	15	min	after	a	bolus	injection	of	0.2	mmol/kg	of	
contrast agent (gadodiamide, Omniscan TM, GE Healthcare). A stack of LV short-
axis	images	was	scanned	using	a	breath-hold	T1-weighted	segmented	inversion-
recovery turbo-FLASH sequence with the following settings: Inversion time to null 
the signal from normal myocardium 250 to 300 ms, repetition time 8.6 ms, echo 
time	4.3	ms,	matrix	256	x	256,	section	thickness	8	mm,	and	intersection	gap	20%.	
Cine magnetic resonance image series came through retrospectively ECG-gated 
segmented steady-state free precession imaging with the following settings: echo 
time	1.51	ms,	repetition	time	3.0	ms,	flip	angle	52°,	matrix	256	x	256,	field	of	view	
240	x	340	mm,	section	thickness	6	mm,	and	temporal	resolution	44	to	47	ms.
We	analyzed	the	images	using	the	same	16-segment	model	as	for	echocardiography	
(Cerqueira et al. 2002). Each segment we assigned a WMS from 1 to 4, as in the 
echocardiographic	analysis	(Lang	et	al.	Recommendations	for	chamber	quantification	
2006). The presence of gadolinium delayed enhancement (DE) in a segment was 
considered	indicative	of	an	MI	scar.	In	each	segment,	the	transmural	scar	extent	
we assessed as the percentage of DE of the wall thickness (Studies I and II). Non-
transmural	infarcts	we	defined	as	segments	with	DE	1	to	50%	showing	normo-	or	
hypokinesia by wall-motion analysis, and transmural infarcts as segments with DE > 
50% showing hypo-, a-, or dyskinesia. In addition, the area of scar in each segment 
we	determined	by	manual	tracing	(Study	IV).	Global	LV	infarct	size	we	calculated	by	
slightly	differing	methods:	In	Study	I,	transmural	scar	extent	in	all	the	LV	segments	
was	averaged;	in	Study	II,	the	transmural	scar	extent	was	averaged	only	in	those	
segments used for global tissue Doppler strain- and strain-rate values; and in Study 
IV, by dividing the sum of segmental scar areas by the total area of all segments.
Repeatability of DE-CMR analyses
In	Study	I,	we	analyzed	a	total	of	384	segments	for	the	presence	of	infarct	by	two	
independent observers. The results of the two observers were concordant for 366 
(95%)	of	the	segments	(κ	=	0.86).
4.4 Body surface potential mapping
Recording and analysis of BSPM
Resting BSPM for 5 minutes was recorded with 120 unipolar leads covering the 
whole	thorax.	The	electrodes	were	5	cm	apart	on	18	disposable	adhesive	strips,	
attached	vertically	on	the	thorax,	with	horizontal	spacing	according	to	anatomic	
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landmarks (Figure 4). In addition, placement of three electrodes in the standard 
limb lead positions provided data for the Wilson central terminal that served as the 
reference potential for the thoracic leads. The BSPM data were recorded with either 
a	Mark6	or	an	ActiveTwo	biopotential	amplifier	(Biosemi,	Amsterdam).
BSPM	data	were	analyzed	with	CAnalyze	software	(Department	of	Biomedical	
Engineering and Computational Science, Aalto University, Espoo, Finland). After 
visual inspection for validity of the recording, the data were signal-averaged 
according	to	criteria	of		≥	0.9	correlation	of	the	QRS	complex	to	a	selected	template,	
and	noise	<	30	µV.	The	T	wave	had	to	fit	in	an	envelope	of	110	to	150	µV	around	
the template (Vaananen et al. 2000). The baseline was estimated by the third-order 
spline	function	fitted	to	consecutive	PQ	segments.	Invalid	leads	were	replaced	by	
interpolating data from surrounding leads based on the method of Oostendorp et 
al. (1989). The QRS start and end were determined automatically from the vector 
magnitude	of	a	representative	precordial	set	of	high-pass	filtered	leads,	following	
the guidelines given by Simson (1981). The J point was determined for each lead 
LA (2)
RA (124)
LL (3)
Mid-clavicular
       line
Mid-clavicular
       lineCenterline
Centerline
FRONT BACK
Figure 4. A) Patient with BSPM leads on the front of 
thorax. B) Layout of the 120 BSPM leads on the front 
and back of the thorax. The horizontal line indicates 
the fourth intercostal space. Squares indicate standard 
ECG leads V1 to V6, shown here as a reference.
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separately	as	the	time	instant	of	the	maximum	curvature	of	the	signal	returning	
to	the	ST	level	around	the	QRS	end.	The	time-points	of	the	apex	and	end	of	the	T	
wave we determined automatically as described elsewhere (Oikarinen et al. 1998).
ECG variables calculated from BSPM
ECG	variables	were	calculated	from	the	QRS	complex,	representing	ventricular	
depolarization,	 as	well	 as	 from	 the	 ST	 segment	 and	 the	T	wave,	 representing	
repolarization.	Computed	ECG	variables	included	amplitudes,	slopes,	time-intervals,	
time-voltage integrals, and time-voltage areas. The time-voltage integral is the sum 
of areas above and below the baseline, whereas the time-voltage area is the sum of 
absolute values of areas above and below baseline. The ECG variables used in the 
study	are	shown	and	defined	in	Table	3.
Table 3. Computed BSPM variables in the studies.
Computed BSPM variables 
Q width Time interval from QRS start to first positive peak, if initial deflection is negative.
R width Time interval from QRS start to first negative peak, if initial deflection is positive.
Ramp Peak (positive or negative) amplitude during the first 15-44.75% of the QRS.
Samp Amplitude of the first opposite-sign peak after the Ramp.
1st QRSint Integral of first quartile of QRS. Describes the Q wave.
2nd QRSint Integral of second quartile of QRS. Describes the R wave.
3rd QRSint Integral of third quartile of QRS. Describes the R- and the S wave.
4th QRSint Integral of fourth quartile of QRS. Describes the S wave.
QRSint Integral of entire QRS complex.
QRSSTTint Integral from onset of QRS to end of T wave.
QRSTTarea Area from onset of QRS to end of T wave.
Jamp Amplitude at J point.
ST60amp =  
STamp
Average amplitude at 58 ms to 62 ms from QRS end. Describes the magnitude 
of ST elevation or ST depression.
ST80amp Average amplitude at 78 ms to 82 ms from QRS end. Describes the magnitude  
of ST elevation or ST depression.
ST60slope Slope from QRS end to 60 ms from QRS end.
ST80slope Slope from QRS end to 80 ms from QRS end.
ST60int Integral between QRS end and 60 ms from the QRS end.
ST80int Integral between QRS end and 80 ms from the QRS end.
STint Integral of first half of interval from QRS end to median T-wave end. Describes 
mainly the ST segment.
STTint Integral from QRS end to T-wave end. Describes ST segment and T wave.
STT area Integral of absolute values from QRS end to median T-wave end. Describes ST 
segment and T wave.
Tamp T-apex amplitude.
T80int = Tint Integral from 80 ms before to 80 ms after T-wave apex. Describes T wave.
TPEint Integral from T-wave apex to T-wave end. Describes second half of T wave.
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4.5 Statistical analyses
Expression	of	continuous	variables	is	as	mean	±	SD.	In	addition,	medians	and	
inter-quartile range are reported (Studies II and III). Inter-quartile range equals 
the range of values falling between the 25th and the 75th percentiles. In all analyses, 
a	p-value	of	<	0.05	was	considered	statistically	significant.
Comparison of groups
Continuous variables were tested for normal distribution, and compared by analysis 
of variance, one-way ANOVA (Studies I and IV), or by the Mann-Whitney U-test 
(Studies II and III). Ordinal variables were compared by the Kruskall-Wallis H-test 
(Study I) and Mann-Whitney U-test (Studies I and III). The Bonferroni procedure 
was applied in multiple comparisons.
Correlation of continuous variables
Two-tailed Pearson’s correlation analysis served to assess correlations in Studies 
I and IV.
Receiver operating curve (ROC) analysis
In Studies II and III, areas under the curve (AUC) were calculated by ROC analysis to 
evaluate	the	sensitivity	and	specificity	of	echo-	and	ECG	variables	to	predict	recovery	
of myocardial function. The variable value yielding the largest sum of sensitivity and 
specificity	became	the	cutoff	value.	Values	better	than	the	cutoff	were	defined	as	
positive. Positive predictive value was calculated as the number of true positives (= 
segments or patients with recovery) divided by the sum of true and false positives. 
The negative predictive value was the number of true negatives (= segments or 
patients without recovery) divided by the sum of true and false negatives.
In	Study	III,	AUC	values	we	first	calculated	for	each	ECG	variable	and	each	lead,	
and	displayed	on	a	color-coded	map.	From	these	AUC	maps,	regions	were	identified	
with the highest AUC values. Then, for each patient, values of the ECG variables in 
these	best-discriminating	regions	we	averaged	from	five	to	nine	contiguous	leads.	
These average values were used to calculate AUC values in order to reduce chance 
effect.
Reproducibility
The	coefficient	of	agreement	‘kappa’	served	to	test	repeatability	of	ordinal	variables.	
A	kappa-value	<	0.19	means	poor	agreement;	0.20–0.39,	fair	agreement;	0.40–0.59,	
moderate	agreement;	0.60–0.79,	substantial	agreement;	and	>	0.8,	almost	perfect	
agreement. In Study I, interobserver agreement for strain mapping was calculated 
by	kappa-statistics	over	the	segments	of	10	randomly	chosen	patients	analyzed	
independently by two observers. In Study II, intraobserver variability was calculated 
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from 100 randomly chosen segments. Kappa statistics served for strain-groups, 
and	the	intra-class	correlation	coefficient	(ANOVA,	two-way	mixed	model,	single	
measures) for all strain- and strain-rate variables.
Statistical software
Statistical calculations were by SPSS 14.0 (Studies I and II), and PASW 18 (Studies 
III and IV).
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5.1 Strain- and strain rate imaging of myocardial ischemic 
injury (I, II)
5.1.1 Validation of strain mapping for myocardial  
function assessment (I)
Strain mapping proved a useful method for estimating segmental and global 
myocardial	contraction	(see	Figures	2	and	3	and	Table	2	in	Methods	for	a	definition	
of	strain	mapping,	pages	46–47).	In	patients	with	chronic	 infarction,	segmental	
systolic strain assessed by strain mapping corresponded well with quantitative, 
end-systolic strain (SES) values. SES	values	significantly	differed	among	groups	of	
segments	as	defined	by	strain-mapping	score	(SMS),	SES values being less negative 
with	increasing	SMS	(Figure	5	A).	Global	SMS	showed	a	significant	linear	correlation	
with global SES score (Figure 5 B).
Segmental SMS was associated with wall-motion score (WMS) assessed visually 
by B-mode echocardiography and CMR: WMS increased with increasing SMS. 
However,	echocardiographic	WMS	did	not	differ	significantly	in	patients	with	SMS	
1 compared with those with SMS 2, which may indicate that echocardiographic 
WMS is less sensitive than SMS in detection of reduced contraction. In contrast, 
WMS	assessed	by	CMR	significantly	differed	between	patients	with	SMS	1	and	
those	with	SMS	2.	Further,	WMS	by	echocardiography	or	CMR	did	not	significantly	
differ between patients with SMS 3 and those with SMS 4, which indicates that 
dyskinesia is not so easily detected by the eye (Figures 5 C and D).
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Figure 5. A) Segments grouped according to strain-mapping score, with their respective quantitative systolic 
strain values. B) Correlation of global strain-mapping scores and global strain scores. C) Segments grouped 
according to strain-mapping score, and their respective wall-motion score by echocardiography. D) Segments 
grouped according to strain-mapping score, and their respective wall-motion score by CMR.
5.1.2 Strain imaging in assessment of chronic MI injury (I)
Systolic strain and extent of MI
Strain	imaging	was	able	to	provide	an	estimate	of	transmural	extent	of	MI	and	
global	 infarct	 size.	 Segmental	 SMS	 and	 end-systolic	 strain	 values	 (SES) both 
reflected	transmural	extent	of	chronic	MI:	The	SMS	was	higher,	and	the	SES less 
negative,	the	higher	was	the	transmural	extent	of	MI	(Table	4).	The	SMS	and	SES 
significantly	differed	in	segments	with	no	or	non-transmural	infarction	than	in	those	
with transmural infarction (Figures 6 A and B). Global SMS and SES each showed 
significant	positive	correlation	with	DE-CMR	measured	global	LV	infarction	size	
(Figures 6 C and D).
p < 0.001 
p < 0.001 
p < 0.001 
1.0 1.5 2.0 2.5 3.0 
(A) 
(C) 
(B) 
(D) p = n.s. 
p = 0.002 
p = n.s. 
p = 0.05 
p = n.s. 
p < 0.001 
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Table 4. Segmental strain-mapping scores and end-systolic strain values according to transmural infarction 
extent.  
Extent of DE, % n Strain-mapping score Strain value, %
0  262 1.3±0.6 -13.6±9.2
1–25  11 1.6±1.0 -14.6±8.7
26-50  21 1.8±1.1 -12.4±10.0
51–75  13 2.3±1.2* -7.1±10.2*
76–100  19 3.1±1.0* -4.3±6.3*
Data presented as mean ± SD. Values differing significantly (p < 0.036) from values in segments 
without DE marked with an asterisk. CMR = cardiac magnetic resonance imaging; DE = delayed contrast 
enhancement.
Figure 6. A) and B) Strain-mapping scores and end-systolic strain values according to infarct transmurality 
by DE-CMR. C) and D) Correlation of global strain-mapping scores and global strain scores with global 
infarction percentage by DE-CMR.
Strain-mapping score vs. echocardiographic WMS in  
estimation of MI scar
Most segments showed normal contraction on echocardiography, with strain 
mapping as well as with B-mode wall-motion analysis. However, a smaller 
proportion of segments had SMS 1 (65%) than had WMS 1 (81%), which may 
indicate that strain mapping is more sensitive in detecting reduced contraction than 
is visual wall-motion analysis. Indeed, of the segments with infarction, 62% had 
SMS	≥	2;	only	53%	had	WMS	≥	2.	Furthermore,	strain	mapping	seemed	clearly	
p < 0.006 p < 0.001 
n=206 n=27 n=25 n=217 n=28 n=27 
(A) (B) 
(C) (D) 
1.0 2.0 2.5 3.0 1.5 
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better at detecting dyskinesia than did wall-motion analysis: The proportion of 
segments with SMS 4 was higher than with WMS 4 (Table 5).
Transmural	MI	extent	was	significantly	higher	 in	segments	with	contraction	
abnormalities than in segments with normal contraction. MI transmurality was also 
significantly	higher	in	segments	with	severely	reduced	contraction	than	in	segments	
with	 slightly	 reduced	contraction.	MI	 transmurality	did	not	differ	 significantly	
among segments with SMS 3 or SMS 4, or among segments with WMS 3 or WMS 
4 (Table 5).
Table 5. Strain-mapping scores and echocardiographic wall-motion scores with corresponding transmural 
infarct extent by DE-CMR. 
Strain-mapping 
score n (%)/258 Extent of DE, % WMS by echo n (%)/285 Extent of DE, %
1 167 (65) 4.7±15.5 1 230 (81) 5.8 ±18.2
2 63 (24) 10.5±24.6 2 30 (11) 21.1± 33.0*
3 9 (3) 44.9±41.1* 3 21 (7) 62.2 ±37.1*
4 19 (7) 57.4±42.1* 4  4 (1) 50.0± 57.7*
Data presented as mean ± SD. Values differing significantly (p < 0.01) from values in segments with 
strain-mapping score 1 or WMS 1 are marked with an asterisk. CMR = cardiac magnetic resonance 
imaging; DE = Delayed contrast enhancement; WMS = wall-motion score by B-mode echocardiography.
 
Accuracy of SMS vs. echocardiographic WMS in detection of transmural infarction
Positive predictive value
Segments with SMS 3 or 4 (representing end-systolic strain values > - 6%) as 
well as segments with WMS 3 or 4 have severely reduced or absent contraction; 
these segments were assumed to be severely damaged. Of the segments with 
SMS	≥	3,	54%	had	transmural	 infarction;	of	the	segments	with	WMS	≥	3,	64%	
had transmural infarction. Of the segments with SMS 4 and WMS 4, indicating 
dyskinesia, a respective 58% and 50% had transmural infarction.
Negative predictive value
Segments with SMS 1 or 2 (representing end-systolic strain values < - 6%) as well 
as segments with WMS 1 or 2 have normal or slightly impaired contraction. Of 
the	segments	with	SMS	≤	2,	96%	had	no	transmural	infarct;	86%	had	no	infarct,	
and	10%	had	a	non-transmural	infarct.	Of	the	segments	with	WMS	≤	2,	94%	had	
no transmural infarct; 85% had no infarct, and 9% had a non-transmural infarct.
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Sensitivity
Of	the	segments	with	transmural	infarct,	60%	had	SMS	≥	3,	and	50%	had	WMS	≥	
3.	Of	those	with	a	transmural	extent	of	MI	>75%,	73%	had	SMS	≥	3,	and	67%	had	
WMS	≥	3;	61%	had	SMS	4,	and	11%	had	WMS	4	indicating	dyskinesia.
Specificity
Of	the	segments	with	no,	or	non-transmural	infarct,	95%	had	SMS	≤	2,	and	96%	
had	WMS	≤	2.
Estimation of global MI size in chronic MI by SMS vs. echocardiographic WMS
Global	SMS,	as	well	as	global	echocardiographic	WMS,	reflected	global	MI	size:	
The higher the score, the larger the infarct. Correlation between global SMS and LV 
infarction percentage was r = 0.758 (p < 0.001); correlation between global WMS 
and LV infarction percentage was r = 0.612 (p = 0.002).
5.1.3 Strain rate imaging in assessment of acute MI injury (II)
Estimation of segmental viability by strain rate imaging
Acutely	measured	segmental	strain-	and	strain-rate	values	showed	a	significant	
correlation	with	final	end-systolic	strain	values	after	recovery,	8	months	later.	SES 
and SPSS showed the best correlations (Figures 7 A and B). Of the segments with 
severely reduced or absent contraction (strain > -7%) in the acute phase, 60% (34 
of	57)	recovered	partly	(final	strain	-7%	to	-12%),	or	completely	(final	strain	≤	-13%).	
These	viable	segments	showed	significantly	better	strain	and	strain	rate	acutely	than	
did non-viable segments (Figures 7 C and D). Accuracy of acute-phase strain- and 
strain-rate variables in predicting recovery of non-contractile segments is shown 
in Table 6. SES and SPSS performed	the	best.	Figure	8	shows	an	example	of	strain	
curves in a patient with MI acutely, and 8 months later, as well as a corresponding 
DE-CMR image.
Transmurality	of	infarction	in	viable	segments	was	significantly	smaller	than	in	
non-viable	segments:	15%	vs.	60%,	p	=	0.006.	The	best	correlation	between	final	
segmental infarction transmurality and acute-phase measurement was for SES (r = 
0.439, p < 0.001), SPSS (r = 0.362, p < 0.001), and SRS (r = 0.318, p < 001).
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Figure 7. A) and B) Correlation between acute end-systolic and post-systolic strain with final end-systolic 
strain after recovery from acute coronary syndrome. Left ventricular segments are grouped according to 
their contraction in the acute phase; segments with a severe contraction abnormality are further divided 
according to recovery: group 1 = normocontractile segments, group 2 = hypocontractile segments, group 3 
= viable segments with a severe contraction abnormality, and group 4 = non-viable segments with a severe 
contraction abnormality. The vertical line indicates the cutoff value with the best accuracy in prediction of 
recovery of segments with a severe contraction abnormality. C) and D) Box-plots of acute end-systolic strain 
and post-systolic strain in non-viable vs. viable segments, each with a severe contraction abnormality (strain 
> -7 %), in patients with acute coronary syndrome. Segments grouped according to recovery of contraction 7 
to 12 months after acute coronary syndrome: non-viable segments that do not recover, and viable segments 
that do recover. End-systolic- and post-systolic strain values are more negative in the viable segments. Each 
box shows the median and inter-quartile range, and whiskers show extreme values.
Table 6. Accuracy of acute-phase strain- and strain- rate parameters in predicting recovery of non-contractile 
segments after acute myocardial infarction. 
Parameter Cut-off value Sens, % Spec, % PPV, % NPV, % AUC p Value
SES, % -1.5 68 74 79 61 0.741 0.002
SPSS, % -3.8 85 62 74 76 0.783 0.001
SRS, s
-1 -0.26 68 70 77 59 0.699 0.011
SRE, s
-1 0.34 79 52 71 63 0.670 0.031
SRA, s
-1 0.25 88 50 72 67 0.724 0.005
Cutoff values represent the point on the receiver operating characteristic curves yielding the best 
accuracy (= highest sum of sensitivity and specificity). Sens = sensitivity; spec = specificity; PPV = positive 
predictive value; NPV = negative predictive value; AUC = area under the curve; SES = end-systolic strain; 
SPSS = post-systolic strain; SRS = systolic strain rate; SRE = early diastolic strain rate; SRA = late systolic strain 
rate.
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Figure 8. A) and B) Strain curves from a patient with MI in the acute phase, and after 8 months. A) In the 
acute phase, end-systolic strain value is positive in the apical segment (red curve), indicating dyskinesia, and 
is severely reduced in the mid-segment (blue,) indicating akinesia. The basal segment (yellow) shows normal 
contraction. The mid-segment shows marked post-systolic strain, suggesting viability. B) After 8 months, 
the mid-segment has recovered, but the apical segment has not. C) DE-CMR image showing transmural 
infarction of the apical septum (red arrow), and subendocardial infarction in the mid- (blue), and basal 
(yellow) segments.
Predicting recovery of global left ventricular function
Global SES and SRS in the acute phase showed good correlation with global SES 
values after recovery (r = 0.760, p < 0.001 and r = 0.732, p < 0.001). Global SES 
and SRS also correlated with global infarction percentage (r = 0.539, p = 0.012 and 
r = 0.440, p = 0.046). Acutely measured global SRE	had	a	significant	correlation	
with	final	global	SES value (r = -0.523, p = 0.01), but not with infarction percentage. 
Global SRA did	not	predict	recovery	or	MI	size.
5.1.4 Feasibility of strain rate imaging (I, II)
In the chronic stage of MI, strain mapping was performed in 26 patients, yielding 
a total of 416 segments (16 segments per patient). Of all segments, 333 (80%) were 
of	sufficiently	good	image	quality	for	strain-mapping	analysis:	Of	156	basal,	134	
(86%), of 156 mid-, 129 (83%), and of 104 apical segments, 70 (67%). SES could be 
measured in 99% of these segments.
In the acute phase, strain rate imaging was performed in 23 patients, yielding a 
total of 414 segments (18 segments per patient). The feasibility of strain and strain 
rate values were as follows: SES 78%, SRS 73%, SRE 73%, and SRA 69%.
5.1.5 Reproducibility of strain rate imaging (I, II)
In order to assess reproducibility, strain mapping was performed in 10 randomly 
selected patients independently by two investigators (Minna Kylmälä and Mika 


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Laine).	 Inter-observer	 agreement	 of	 SMS	 was	 substantial:	 the	 coefficient	 of	
agreement “kappa” was 0.63 between the two observers.
Intra-observer variability of acute-phase strain- and strain-rate values was tested 
in	10	randomly	chosen	patients.	The	 intra-class	correlation	coefficients	were	as	
follows: SES 0.87, SPSS 0.93, SRS 0.77, SRE 0.67, and SRA 0.53.
5.2 Body surface potential mapping of myocardial ischemic 
injury (III, IV) 
5.2.1 BSPM in assessment of chronic MI injury (IV)
5.2.1.1 Correlation of BSPM variables with infarct size in chronic MI 
BSPM	variables	are	explained	in	Table	3	in	the	Methods	section,	page	50.	The	best	
correlations of BSPM variables and their corresponding leads are shown in Table 
7 and Figure 9.
Depolarization variables
Variables	from	the	first	half	of	the	QRS,	comprising	the	Q-	and	R	waves,	showed	
strong correlations with infarct percentage by DE-CMR, their best correlations being 
on the left side of the chest, and reciprocally on the right upper back, with inverse 
correlations at these two sites. On the upper back, the QRS is a mirror image of the 
QRS on the left side: The “reciprocal Q wave” is represented by an initial positive 
deflection,	and	the	“reciprocal	R	wave”	a	negative	deflection;	the	“reciprocal	S	wave”	
a	positive	deflection.
The initial QRS variables, 1st QRSint and R width, had their strongest correlations 
reciprocally on the right upper back (r = 0.57 and r = 0.71). On the upper back, R 
width	was	measured	as	the	time	from	QRS	onset	to	the	first	negative	deflection,	
hereafter called “reciprocal Q width.” On the left side, Q width was measured as 
time	from	QRS	onset	to	the	first	positive	deflection.	However,	on	the	left	side,	the	
correlation of the Q width (r = 0.51) was clearly lower than that of the reciprocal 
Q width on the upper back. Also the 1st QRSint had a clearly weaker correlation on 
the left side (r = -0.38).
The 2nd QRSint and Ramp, describing the R wave, had their strongest correlations 
on the left side (r = -0.56 and r = -0.57). The inverse correlations of the reciprocal 
R-wave variables on the right upper back were almost as good (r = 0.53 and r = 
0.55). The QRSint had a strong correlation on the left side (r = -0.58), and a weak 
inverse correlation on the upper back (r = 0.34).
Variables	from	the	second	half	of	the	QRS,	comprising	the	S	wave	and	the	final	
part	of	the	R	wave,	showed	significant,	but	weak	correlations.	The	Samp	performed	
the best on the central upper back (r = -0.42), with a weaker correlation on the left 
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side (0.39). The 3rd and 4th	QRSint	showed	significant	correlations	on	the	left	side	
only (r = -0.39 and r = 0.33, respectively).
Repolarization variables
Repolarization	variables	performed	best	 on	 the	 left	 side	 around	 lead	V5,	with	
significant	inverse	correlations	with	infarct	size	reciprocally	on	the	right	upper	back	
as well. The T-wave variables had slightly stronger correlations than the variables 
including the ST segment in addition to the T wave. The correlations of Tamp, 
T80int, and TPEint were negative on the left side (r = -0.55, r = -0.57, and r = 
-0.56). The STTint and QRSSTTint also showed negative correlations on the left 
side (r = -0.52 and r = -0.54). Reciprocally, the correlations for all these variables 
were	weaker	(r	=	0.43–0.49).	Diverging	from	the	other	repolarization	variables,	
the QRSSTT area showed a strong negative correlation on right upper back (r = 
-0.50), and a weaker inverse correlation on the left shoulder (r = 0.42).
ST-segment	amplitudes,	 slopes,	and	 integrals	had	weak,	or	non-significant,	
correlations. ST60amp, STint, ST80amp, and ST80 slope performed the best on 
the left upper back (r = -0.3 to -0.36); the ST60 slope had a weak correlation on 
the left side (r = 0.27). Jamp showed a weak correlation on the right upper back (r 
= 0.28) and on the left side (r = -0.27); the other ST-segment variables showed no 
significant	reciprocal	correlations.	The	ST60int	and	ST80int	showed	no	significant	
correlations at all.
5.2.1.2 BSPM variables differentiating large from small infarcts in chronic MI
The	best-performing	depolarization	and	repolarization	variables	could	distinguish	
patients with large infarcts (LV infarct percentage by DE-CMR > 11%, the median) 
from those with a small or with no infarct (Figure 9). In large infarcts, the reciprocal 
Q width was wider, and the 1st QRSint was positive or less negative on the right 
upper back. On the left side, close to V3 and V4, the Ramp and the 2nd QRSint 
were negative, or were positive but less positive, indicating a smaller, or an absent 
R wave in large infarcts. At the same site, the QRSint was negative, or less positive, 
in large infarcts. Also on the left side, the Tamp, T80int, STTint, and QRSSTTint 
were negative, or less positive, due to negative, or lower T waves in large infarcts. 
Figure	10	shows	QRSSTT	examples	demonstrating	differences	in	depolarization-	
and	repolarization	variables	between	patients	with	large	infarcts	and	patients	with	
no infarct scar.
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Figure 9. A) to D) Computed BSPM variables in the chronic phase at the lead yielding the highest correlation 
with MI size, in patients with large, small, or no infarct. On the left: Boxes indicate medians, first and third 
quartiles; whiskers indicate minimum and maximum values falling within 1.5 x the interquartile range from the 
upper or lower edge of the box; extreme values are indicated by points falling outside 1.5 x the interquartile 
range. Large and small infarcts are separated by the median infarction percentage, 11%, by DE-CMR. On the 
right: Scatterplots showing correlations between BSPM variables and infarction percentages. For definition 
of BSPM variables, see Table 3. 
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Figure 10. Representative QRSSTT complexes demonstrating differences in BSPM variables between patients 
with a large infarct scar (right) or with no infarct scar (left). A) R width (time-interval marked on the initial 
QRS) and 1st QRSint (blue area) on the upper back (lead 112). B) Ramp (peak of positive deflection), 2nd 
QRSint (hatched area), and QRSint (integral of the yellow area) on the left side (lead 54). C) Tamp (T-apex 
amplitude, marked by a line), T80int (green area), TPEint (time from T-apex to T-end), and STTint (hatched 
area) on the left side (lead 72). QRSSTT complexes are recorded in the chronic phase; examples shown are 
from leads yielding the highest correlations with MI size.
5.2.2 BSPM in assessment of acute MI injury (III, IV)
5.2.2.1 Correlation of BSPM variables with infarct size in acute MI and during 
recovery (IV)
BSPM	variables	are	explained	in	Table	3	 in	the	Methods	section,	page	50.	The	
best	correlations	of	BSPM	variables	with	infarct	size	by	DE-CMR—along	with	their	
corresponding leads—are shown in Table 7.
BSPM in the acute phase vs. infarction percentage
The same depolarization variables that correlated best with infarction 
percentage	in	the	chronic	phase	also	showed	strong	correlations	acutely	with	final	
MI	size.	In	the	acute	phase,	the	best	recording	locations	were	the	same	as	in	the	
chronic phase. The Q-wave variables had slightly lower correlations, and R-wave 
variables had slightly higher correlations in the acute than in the chronic phase. The 
1st QRSint and reciprocal Q width showed their strongest correlations on the upper 
back (r = 0.56 and r = 0.64). Q width had a strong correlation on the left side (r 
= 0.59) whereas that of the 1st QRSint was weak (r = -0.39). The 2nd QRS, Ramp, 
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and QRSint showed their strongest correlations on the left side (r = -0.59, r = -0.60 
and r = -0.62). The 2nd QRS and Ramp also showed strong inverse correlations 
reciprocally on the right upper back (r = 0.50 and 0.52), whereas the QRSint had 
only a weak correlation reciprocally (r = 0.28). Samp had a good correlation on 
the central upper back (r = -0.51), and a weaker correlation on the left side (r = 
0.40). The 3rd and 4th	QRSint	had	significant	correlations	on	the	left	side	only	(r	=	
-0.43 and r = 0.32).
Repolarization variables showed clearly weaker correlations with infarction 
percentage acutely than they did in the chronic phase, but the best recording 
locations were the same. The QRSSTTint and the Tamp performed best, with 
negative correlations on the left side (r = -0.42 and r = -0.40). Moreover, the T80int 
and	TPEint	had	significant	correlations	on	the	left	side	(r	=	-0.36	for	both).	The	
QRSSTT area showed a moderate correlation on the upper back (r = -0.35). These 
repolarization	variables	showed	no	significant	reciprocal	correlations.	ST-segment	
variables had weak correlations of similar magnitude as in the chronic phase. ST-
segment amplitudes and -integrals performed best on the right side (r = -0.29 to 
-0.33), ST60- and ST80 slopes on the left lower back (r = -0.28 for both). Only the 
STTint	lacked	significant	correlations	acutely.
BSPM during recovery vs. infarction percentage
At	(a	mean)	2	weeks	(1–4	weeks)	after	the	acute	event,	during	healing	of	the	infarct,	
recording locations providing the best data were the same as in the acute and chronic 
phases. Depolarization variables	 from	the	first	half	of	 the	QRS	performed	
best, their correlations being as strong as in the acute and chronic phases. Q-wave 
variables had slightly higher, and R-wave variables slightly lower correlations during 
recovery than in the acute phase. Reciprocal Q width and the 1st QRSint showed 
strong correlations on the right upper back (r = 0.65 and r = 0.56). On the left side, 
Q width and 1st	QRSint	showed	significant,	albeit	weaker,	correlations	(r	=	0.47	
and r = -0.48). The 2nd QRSint, Ramp, and QRSint showed strong correlations on 
the left side, below V3 and V4 (r = -0.59, r = -0.59, and r = -0.58). The 2nd QRSint 
and Ramp also had strong inverse correlations reciprocally on the upper back (r = 
0.56 and r = 0.57), whereas the inverse correlation for QRSint was clearly weaker 
(r = 0.34). Of the variables from the second part of the QRS, Samp performed the 
best on the right upper back (r = -0.53), slightly better than in the acute or chronic 
phases. The 3rd	QRSint	had	a	significant	correlation	on	the	left	side	only	(r	=	-0.41);	
the 4th	QRSint	showed	no	significant	correlations	during	recovery.
Repolarization variables performed clearly better during recovery than they 
did acutely, and almost as well as in the chronic phase. The T-wave variables Tamp, 
T80int, and TPEint performed the best, with strong correlations on the left side (r = 
-0.54,	r	=	-0.52,	and	r	=	-0.54).	The	STTint	and	the	QRSSTTint	also	had	significant	
correlations	on	the	left	side	(r	=	-0.38	and	r	=	-0.50).	All	these	repolarization	variables	
had	significant,	albeit	weaker,	correlations	reciprocally	on	the	right	upper	back	(r	
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=	0.33–0.39).	The	QRSSTT	area	had	a	strong	correlation	on	the	right	upper	back	
(r	=	-0.51),	without	any	significant	reciprocal	correlation.	ST-segment	variables	
showed the weakest correlations of all, similar to those in the acute and chronic 
phases, at best r = 0.28 to 0.36 on the left shoulder. ST60- and ST80 slopes had 
their best correlations on the lower right back (r = -0.3 and -0.32, respectively).
Correlation of BSPM variables with CK-MBm in acute MI (IV)
In the acute phase, depolarization variables correlated better with peak CK-
MBm	than	did	repolarization	variables,	as	they	also	did	with	infarction	percentage,	
and at the same locations. The 2nd QRSint and Ramp performed the best, with strong 
correlations on the left side (r = -0.56 and r = -0.59), and even stronger inverse 
correlations reciprocally on the right upper back (r = 0.63 and r = 0.64). Q width 
showed strong correlations on the left side (r = 0.57), and reciprocally on the right 
upper back (r = 0.57). However, the 1st QRSint showed only a moderate correlation 
on the central upper back (r = 0.42), and an even weaker inverse correlation on the 
left side. As for the correlations with infarction percentage, the second part of the 
QRS	performed	worse	than	the	first	part.	Again,	Samp	had	moderate	correlations	
on the left side (r = 0.46), and the central upper back (r = -0.47), whereas the 3rd 
and 4th QRSint had weaker correlations.
Of the repolarization variables,	those	confined	to	the	ST	segment	performed	
best, with the best recording location on the left side. ST60- and ST80 amplitudes 
and	-slopes	showed	good	correlations	with	CK-MBm	on	the	 left	side	(r	=	0.51–
0.56), and ST60int, ST80int, STint, and Jamp had moderate correlations on the left 
side	(r	=	0.43–0.47).	All	ST-segment	variables	had	significant	inverse	correlations	
reciprocally on the right side, or right upper back (r = -0.41 to -0.49). However, the 
variables	including	the	T	wave	showed	no	significant	correlations	at	any	locations,	
except	for	QRSSTTint,	with	its	borderline	significant	correlation	on	the	right	upper	
back (r = -0.28).
Peak CK-MBm had a good correlation with infarction percentage by DE-CMR (r 
=	0.65),	thus	reflecting	final	MI	size.	In	the	chronic	phase,	depolarization	variables	
showed correlations as good as in the acute phase, again performing better than 
the	repolarization	variables	did.	With	infarction	recovery,	correlations	of	T-wave	
variables grew stronger, and those of ST-segment variables diminished. In the 
chronic phase, the leads on the upper back yielded stronger correlations for the 
best	depolarization	as	well	as	repolarization	variables.
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Table 7. Best correlations of BSPM variables with LV infarct percentage at various time-points of myocardial 
infarction. 
 Acute phase Recovery phase Chronic phase
r max p-value Lead r max p-value Lead r max p-value Lead
1st QRSint 0.56 < 0.0001 112 0.56 < 0.0001 112 0.57 < 0.0001 112
2nd QRSint -0.59 < 0.0001 61 -0.59 < 0.0001 55 -0.56 < 0.0001 54
QRSint -0.62 < 0.0001 54 -0.58 < 0.0001 55 -0.58 < 0.0001 54
Ramp -0.60 < 0.0001 67 -0.59 < 0.0001 62 -0.57 < 0.0001 61
Samp -0.51 < 0.0001 104 -0.53 < 0.0001 113 -0.42 0.001 105
R width* 0.64 < 0.0001 112 0.65 < 0.0001 112 0.71 < 0.0001 112
Q width 0.59 < 0.0001 71 0.47 0.0003 61 0.51 < 0.0001 60
ST60 -0.30 0.02 5 0.36 0.008 63 -0.30 0.02 88
ST80 -0.33 0.01 5 0.29 0.04 63 -0.35 0.008 80
STint -0.30 0.03 5 0.28 0.04 63 -0.31 0.02 81
ST60 slope 0.32 0.01 55 -0.30 0.03 115 0.27 0.04 70
ST80 slope 0.28 0.04 47 -0.32 0.02 115 -0.36 0.006 88
Tamp -0.40 0.002 75 -0.54 < 0.0001 72 -0.55 < 0.0001 72
T80int -0.36 0.006 75 -0.52 < 0.0001 72 -0.57 < 0.0001 72
TPEint -0.36 0.006 71 -0.54 < 0.0001 72 -0.56 < 0.0001 72
STTint n.s. -0.38 0.004 72 -0.52 < 0.0001 72
QRSSTTint -0.42 0.001 71 -0.50 0.0001 69 -0.54 < 0.0001 69
QRSSTT area -0.35 0.007 119 -0.51 < 0.0001 111 -0.50 < 0.0001 111
*R width = “reciprocal Q width.” 
For definition of BSPM variables, see Table 3.
5.2.2.2 Predicting recovery of LV function with BSPM in acute MI (III)
BSPM variables could assess myocardial viability in patients with acute MI. Viability 
was determined by comparing the proportion of dyssynergic LV by echocardiography 
in the acute phase and after healing of the infarct, on average 11 months after the 
acute event. If, between measurements, the number of dysfunctional segments had 
decreased, the myocardium was considered viable. In the acute phase, the number 
of dysfunctional segments was slightly higher in patients with viable myocardium 
than in those without: 5.7 ± 2.1 vs. 4.4 ± 2.4 (p = 0.017). After MI healing, the 
number of dysfunctional segments was 1.9 ± 1.7 vs. 6.5 ± 2.6, and EF was 60 ± 8% 
vs. 49 ± 9% in the viable vs. the non-viable group (both p > 0.001).
Acute-phase BSPM variables best in predicting recovery of LV function differed 
for	all	three	culprit-artery-defined	ischemic	regions,	as	did	the	best	recording	location	
with the highest predictive accuracy. The best recording location differed between 
depolarization	and	repolarization	variables	(Table	8).	For	most	BSPM	variables,	
we found also a reciprocal recording location, with good predictive accuracy for the 
inverse values of the BSPM variables at the best recording locations.
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Table 8. Best-performing BSPM variables and their accuracy in predicting left ventricular recovery. 
BSPM 
Variable
Cut- 
off
Sens,  
%
Spes,  
%
PPV,  
%
NPV,  
%
Recording site AUC P-Value 
LAD group
1st QRS quartile -0.15 85 79 85 79 around V4–V6 0.821 0.002
STT integral -9.03 80 71 80 71 left upper back and neck 0.786 0.005
RCA group
1st QRS quartile 2.22 91 80 91 80 upper sternum 0.891 0.015
ST integral 1.3 100 80 92 83 upper sternum 0.982 0.003
LCX group
STT area 8.98 100 83 86 100 around V6–V7 0.972 0.006
The unit for BSPM variables is mVms. “Median” indicates median value of the average integrals calculated 
in each patient from the best recording site; “cutoff,” the average integral value yielding the highest sum 
of sensitivity and specificity. For definition of BSPM variables, see Table 3. AUC = area under the curve, 
LAD = left anterior descending coronary artery, LCX = left circumflex coronary artery, NPV = negative 
predictive value, PPV = positive predictive value, Sens = sensitivity, Spes = specificity, RCA = right 
coronary artery, V4 – V7 = standard ECG chest leads.
Optimal recording locations
Figure 11 shows the best recording locations for predicting recovery of the LV 
territories by culprit artery.
The	best	recording	location	for	predicting	recovery	of	LAD–defined	dysfunction	
was on the left side around standard leads V4 to V6. Here, of all BSPM variables, 
the 1st	QRSint	performed	the	best.	Repolarization	variables	predicted	LAD-defined	
dysfunction best on the left upper back and neck, and the upper sternum performed 
rather well, as did the best reciprocal recording site on the lower chest centrally.
The best recording location for predicting recovery of RCA-defined LV 
dysfunction was on the upper sternum and in the region below the right clavicle. 
Here,	STint	and	other	repolarization	variables	performed	best.	The	right	upper	back	
and neck were also equally good recording sites. The best reciprocal recording site 
was on the left side, at or below standard lead V5.
For	 predicting	 recovery	 from	LCX-defined	 dysfunction,	 the	 best	 recording	
location was on the posterior left side, around standard leads V6 and V7.
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Figure 11. Best recording locations for predicting recovery of various culprit-artery defined ischemic territories. 
Best reciprocal recording locations indicated with an r. LAD = left anterior descending coronary artery, LCX 
= left circumflex coronary artery, RCA = right coronary artery.
Best depolarization variables
In the LAD group, the 1st QRSint was the very best variable at predicting functional 
recovery, with its optimal recording site being on the left side (AUC 0.82, p = 0.002). 
Here, the group medians were 1.01 mVms in patients recovering vs. -1.33 mVms 
in those not recovering (Table 8). At the best reciprocal recording site on the right 
back, the group median 1st QRSint in patients recovering, was negative, and in those 
not recovering, positive (Figure 12). The torso map of the 1st QRSint in the recovery 
group resembled that of the healthy controls very closely.
In the RCA group also, the 1st	QRSint	was	the	best	of	the	depolarization	variables	
for predicting functional recovery, with its optimal recording site being on the upper 
sternum (AUC 0.89, p = 0.015). Here, the group medians were 1.72 mVms in 
patients recovering vs. 2.66 mVms in those not recovering (Table 8). Recovery of 
the RCA territory could also be accurately predicted reciprocally from the left side, 
where the group median 1st QRSint was less negative in patients recovering than 
in those not recovering (Figure 12).
In the LCX group, the 4th QRSint, recorded on the left side of the back, was less 
positive in patients recovering than in those not recovering. Reciprocally on the right 
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shoulder, the 4th QRSint was positive in patients recovering, and negative in those 
not recovering. However, its discriminatory accuracy was not strong (Figure 12).
Figure 12. Best depolarization variables in patients with and without recovery according to culprit artery, and 
the corresponding AUC values showing the best recording locations with the highest predictive accuracy.
Best repolarization variables
The STint, STTint, and STT area performed well at predicting recovery of both 
LAD-	and	RCA-defined	LV	dysfunction.	At	the	best	recording	site,	the	STint	and	
STTint were less negative and the STT area smaller in patients recovering than in 
those not recovering from LAD-related LV dysfunction. Relationships between these 
variables and recovery of RCA-related dysfunction were the opposite.
In	the	LAD	group,	STTint	was	the	best	of	the	repolarization	variables,	with	its	optimal	
recording site being on the left upper back and neck (AUC 0.79, p = 0.005). Here, 
the group medians were -5.52 mVms in patients recovering vs. -10.65 mVms in 
those not recovering from LV dysfunction (Table 8). STTint performed in a similar 
fashion also on the upper sternum. The best reciprocal recording site was centrally 
on the upper abdomen, where the STTint was less positive in patients recovering 
than in those not recovering. STint had a discriminatory pattern similar to that of 
STTint. The STT area was smaller in patients recovering than in those not recovering 
at all these aforementioned recording sites (Figure 13).
LAD, 1st QRS integral 
RCA, 1st QRS integral 
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In the RCA group, STint was the best variable of all, with its optimal recording site 
including the region below the right clavicle and the upper sternum (AUC 0.98, p 
=	0.003).	Here,	the	group	medians	were	–3.90	mVms	in	patients	recovering	vs.	
2.37 mVms in those not recovering from LV dysfunction (Table 8). The region that 
included the right upper back and neck, was an equally good discrimination site. The 
best reciprocal recording site was on the left side, where STint was positive in patients 
recovering, and negative in those not recovering. STTint, as well as STamp, had a 
similar discriminatory pattern as STint. STT area was larger in patients recovering 
than in those not recovering at all these sites (Figure 13).
In the LCX group, STT area was the best variable at predicting recovery, with the 
optimal recording site being on the left side (AUC 0.97, p = 0.006). Here, the 
group medians were 15.19 mVms in patients recovering vs. 7.77 mVms in those 
not recovering (Table 8). No variables other than STT area could reliably predict 
recovery of LCX-related LV dysfunction (Figure 13).
T-end integral and T-wave integral could predict recovery of the LAD territory 
in a manner similar to that of the STint and the STTint. At the best recording 
locations on the left shoulder and the upper sternum, these variables were less 
negative in patients recovering than in those not recovering. The T-end integral 
predicted recovery of the RCA territory also. As for STint, STTint, and STamp, the 
best recording locations were on the upper sternum, below the right clavicle, and on 
the right shoulder, at which sites the T-end integral was more negative in patients 
recovering than in those not recovering (Figure 13).
The	torso	maps	of	all	repolarization	variables	in	the	RCA-	and	LCX-	recovery	
groups resembled those of the healthy controls. In the LAD group, both patient 
groups had torso maps similar to those of healthy controls (Publication III, 
supplementary Figure S4).
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Figure 13. A) to C) Best repolarization variables in patients with and without recovery according to culprit 
artery, and corresponding AUC-values showing the best recording locations with the highest predictive 
accuracy. A) LAD, left anterior descending artery; B) RCA, right coronary artery; C) LCX, left circumflex 
coronary artery.
(A) 
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Figure 2. Upper row: Average body surface potential maps in healthy controls and in the RCA group of the ST integral.
“Recovery” and “Nonrecovery” refer to the group of patients with versus without recovery of left ventricular function.
Lower row: The AUC-map showing single-lead AUC values for the ST integral in distinguishing between patients with
recovery and those without, and representative patient examples of body surface potential maps of the ST integral in the
RCA group. Recovery refers to a patient with six acutely dysfunctional segments, four of which recovered. Nonrecovery
refers to a patient with five acutely dysfunctional segments, and six at follow-up. In the individual maps, front chest is
to the left, back chest to the right. RCA = right coronary artery; ST integral = integral of the first half of the interval
from QRS end to T-wave end.
or spontaneous reperfusion. We repeated echocar-
diography after 11 months in order to determine
recovery of regional wall motion. At inclusion—
irrespective of LV recovery—ejection fraction,
maximal CK-MBm release, proportion of patients
with Q waves, and patients with ST-elevation
infarctions (about 80%) were the same. We
found that computed ECG variables from BSPM
differentiated between patients with reversible LV
dysfunction and those with permanent injury.
The best-differentiating ECG variable depended
on the region of ischemic injury. Overall, the
repolarization variables could predict recovery,
associated with less final damage, in all three major
culprit-artery regions. In the LAD-related region
of LV dysfunction, the first QRS integral outper-
formed the repolarization variables in predicting
recovery of LV function. The best ECG variable
in predicting recovery of the RCA region was the
ST integral, and that of the LCX region was the
STT area. Interestingly, the values of all these best-
performing variables reminded those of healthy
controls in the recovery groups.
The Best ECG Variables in Predicting
Recovery
Depolarization Variables
Interestingly, the first QRS integral, the “com-
puted Q wave,” was the best ECG variable in
predicting recovery of the LAD region. The best
discrimination site was around standard leads V4–
V6, where the integrals in the nonrecovery group
were mainly negative, equal to a Q wave, and
positive in the recovery group. The first QRS
integral was also the best of the depolarization
variables in predicting recovery of the RCA region.
The best-discriminating site was on the upper
sternum, where the integrals were more positive
in the nonrecovery group than in the recovery
group, a finding which could be due to a more
upward electrical axis in an inferior infarction. The
values of the first QRS integrals in healthy controls
resembled more those in the recovery than in the
nonrecovery groups. No depolarization variables
could convincingly predict recovery of the LCX
region.
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6 DISCUSSION
6.1 Main findings
The aim of this thesis was to learn whether echocardiographic strain rate imaging 
and	electrocardiographic	BSPM	can	estimate	myocardial	viability	and	infarct	size	
in patients with acute and chronic MI. DE-CMR performed after healing of the 
infarction served as the gold standard for determining segmental as well as global 
LV	infarct	size.
In patients with chronic MI, tissue Doppler strain-mapping was validated for 
assessing	regional	systolic	strain	and	extent	of	infarct,	to	our	best	knowledge,	for	
the	first	time.	Systolic	strain,	measured	quantitatively	as	well	as	by	strain	mapping,	
could differentiate between segments with transmural infarct and those with non-
transmural, or no infarct. Global systolic strain and BSPM variables correlated with 
MI	size	in	chronic	MI.
In patients with acute MI, strain- and strain-rate variables could assess myocardial 
viability, and predict recovery of contraction of akinetic segments. Acutely measured 
global	strain-	and	strain-rate	variables	reflected	LV	function	after	healing	of	the	
infarction,	and	correlated	with	final	MI	size.	Moreover,	acute-phase	BSPM	variables	
correlated	with	final	MI	size	and	could	predict	recovery	of	LV	function.
6.1.1 Validation of strain mapping in chronic MI
Systolic strain is a measure of myocardial contraction possible to quantify by tissue 
Doppler echocardiography. In modern ultrasound machines, tissue Doppler strain 
can be color-coded and displayed in real-time on top of the two-dimensional image. 
Systolic strain values can then be semi-quantitatively assessed from these strain 
maps, a method that we call strain mapping. In Study I, strain mapping was, for the 
first	time,	validated	for	assessing	regional	systolic	strain	and	extent	of	chronic	MI.
Systolic strain was scored by strain mapping: Score 1 for normal contraction; 
scores 2, 3, and 4 for increasing degrees of contraction abnormality. Strain mapping 
showed itself to be feasible and repeatable, with substantial inter-observer agreement 
for strain-mapping scores (SMS). Segmental and global SMS of the LV showed 
excellent	agreement	with	corresponding	quantitative	systolic	strain	values.
SMS	reflected	the	segmental	extent	of	chronic	MI;	the	higher	the	score,	the	larger	
the	transmural	extent	of	 infarct.	SMS	could	separate	segments	with	transmural	
infarct	 (extent	of	MI	>	50%	of	 the	segmental	 thickness)	 from	those	with	non-
transmural or no infarct, performing equally well as quantitative strain values. 
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Strain mapping as well as quantitative strain analysis failed, however, to separate 
segments with non-transmural infarct from those with no infarct. Global SMS, 
as well as global strain by quantitative analysis, showed a strong correlation with 
global LV infarction percentage by DE-CMR (r = 0.76 and r = 0.74, respectively).
In comparison to visual wall-motion scoring (WMS) of segmental contraction, 
strain mapping was as good at ruling out transmural infarction in patients with 
chronic	MI,	at	a	specificity	of	95%.	SMS	1	or	2,	indicating	normal	or	moderately	
reduced	contraction,	excluded	transmural	MI	with	an	excellent	negative	predictive	
value	of	96%.	SMS	3	or	4,	indicating	severely	reduced	or	absent	contraction,	signified	
in most cases that the segment had an infarct, one which probably was transmural. 
In segments with SMS 1 and 2 respectively, WMS was closer to 1, which could 
signify that strain mapping is more sensitive than WMS at identifying segments 
with a mild contraction abnormality. WMS was around 2.5 in segments with SMS 
3 and 4, indicating that strain mapping is more sensitive than is the eye at detecting 
dyskinesia.	Supporting	this	finding,	segments	with	a	transmural	extent	of	infarct	
> 75% were at SMS 4 for dyskinesia in 61%, and WMS 4 for dyskinesia only in 
11% of cases.
6.1.2 Strain- and strain rate imaging in assessment of  
viability and extent of MI
If myocardium contracts, it is viable. Myocardial segments with systolic strain values 
more negative than -7% have preserved contraction, and therefore are viable. Study 
II showed that in patients with acute MI, strain- and strain-rate values could assess 
myocardial viability. Acute-phase segmental strain- and strain-rate values correlated 
with	final	end-systolic	strain.	These	variables	could	predict	with	good	accuracy	
whether segments with severely reduced or absent contraction (end-systolic strain 
>	-7%)	would	recover:	These	variables	were	significantly	better	in	viable	segments	
with functional recovery than in non-viable segments not recovering. The most 
accurate variable in assessment of viability (AUC = 0.78), was post-systolic strain, 
followed by end-systolic strain; systolic and diastolic strain rates were also good at 
predicting recovery of non-contractile segments, but performed no better than strain 
did. Global values of acute systolic strain and strain rate, as well as early diastolic 
strain	rate,	correlated	with	final	global	systolic	strain	values,	and	thus	predicted	
final	LV	systolic	function.
Myocardial	viability	and	contraction	are	connected	with	the	transmural	extent	
of MI. In both acute and chronic MI, segmental systolic strain values became less 
negative with increasing transmurality of the infarct. In acute MI, systolic strain, 
post-systolic	strain,	and	systolic	strain	rate	showed	significant	correlations	with	
segmental infarct transmurality. In viable non-contractile segments with functional 
recovery after the acute event, median infarction percentage was 19%, as compared 
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with non-viable segments with a median infarction percentage of 60%. In both 
acute and chronic MI, global systolic strain—and acutely also global systolic strain 
rate—showed	good	correlations	with	LV	infarction	percentage,	reflecting	the	global	
extent	of	MI.	The	less	negative	the	values,	the	larger	the	MI	size.
6.1.3 BSPM in assessment of viability and MI size
BSPM	records	cardiac	electric	potentials	by	leads	covering	the	entire	thorax,	and	
thus yields ECG data from a much larger thoracic area than the conventional 12-
lead ECG. From the BSPM recordings, a multitude of different variables related 
to	the	QRSSTT	complex	can	be	automatically	calculated.	Studies	III	and	IV	show	
that	at	all	stages	of	the	infarction,	BSPM	variables	can	determine	final	MI	size.	In	
acute MI, BSPM variables can predict recovery of dysfunctional myocardium. Thus, 
BSPM	can	assess	myocardial	viability	as	well	as	LV	infarct	size.
At	 all	 stages	 of	 the	 infarction,	 depolarization	 variables	 were	 better	 than	
repolarization	 variables	 at	 estimating	MI	 size,	 the	 computed	Q-	 and	R	waves	
performing best. At all time-points, the best recording sites were on the left side, 
in the vicinity of V3 to V5, and reciprocally on the right upper back. Interestingly, 
the computed Q wave performed the best reciprocally, where the QRS values are the 
inverse	to	those	on	the	left	side,	a	reciprocal	Q	wave	being	a	positive	deflection.	Leads	
at a distance may see the heart in more of a panorama view than do leads overlying 
the	LV,	which	could	explain	why	the	right	upper	back	was	a	good	recording	site,	
especially in a patient group including multiple MI locations. In comparison with 
the Q- and R-wave variables, the QRS variables from the second half of the QRS 
showed	only	modest	correlations	with	MI	size.	The	T-wave	variables	had	moderate	
correlations	with	MI	size	in	the	acute	phase,	correlations	that	grew	stronger	during	
recovery; in the chronic phase, the T-wave variables performed nearly as good as 
the R-wave variables. The ST-segment variables had only weak correlations with 
MI	size,	regardless	of	infarction	stage.
BSPM variables could predict recovery of dysfunctional myocardium in patients 
with acute MI, irrespective of clinician-assessed Q-wave status in the 12-lead ECG, 
EF, or peak CK-MBm. The best variables and best recording sites differed depending 
on MI location. The best variable at predicting LAD-related LV dysfunction was the 
1st QRSint on the left side at, or above V3 to V6. The 1st QRSint performed well also 
at predicting recovery from RCA-related LV dysfunction, with the best recording 
site	on	the	upper	sternum.	No	other	QRS	integrals	were	useful,	except	for	the	4th 
QRSint that seemed to predict recovery from LCX-related LV dysfunction on the 
posterior	left	side.	Regarding	repolarization,	variables	containing	the	ST	segment	
performed best, the STT area being the only variable capable of assessing viability 
irrespective	of	MI	 location.	Repolarization	variables	predicted	recovery	of	RCA-	
and LCX-related LV dysfunction better than did QRS variables. The best recording 
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site for predicting RCA-related LV dysfunction was the right upper back and the 
region including the upper sternum and the right clavicle; the best recording site 
for predicting recovery from LCX-related dysfunction was on the left side around 
V6	and	V7.	At	these	optimal	recording	locations,	the	best	repolarization	variables	in	
patients recovering resembled those in healthy controls more than did the variables 
in	patients	not	recovering.	The	repolarization	variables	were	also	good	predictors	
of LAD-related LV dysfunction, although not as strong as was the 1st QRSint, with 
their best recording site on the left upper back and neck.
Of all BSPM variables, only the 1st	QRSint	was	a	good	estimator	of	both	final	
infarct percentage and viability in acute MI: Patients with a computed Q wave had a 
larger infarct and less viable myocardium. The ST-segment variables that predicted 
recovery of LV function showed only weak correlations with infarct percentage in 
the acute phase. This could indicate that within 48 hours after onset of chest pain, 
in	patients	reperfused	 for	acute	MI,	 the	ST	changes	reflect	 the	size	of	stunned	
myocardium	more	than	of	final	MI	size.	In	the	acute	phase,	ST-segment	variables	
correlated	fairly	well	with	peak	CK-MBm,	but	poorly	with	final	infarction	percentage	
by	DE-CMR—another	indication	that	the	ST	segment	reflects	the	size	of	viable,	but	
dysfunctional myocardium early after reperfusion.
6.2 Findings in the context of previous studies
6.2.1 Evaluation of myocardial ischemic injury
Established	imaging	techniques	for	direct	quantification	of	MI	size	and	assessment	
of myocardial viability are DE-CMR, SPECT, and PET. These techniques have 
served as a reference in validation studies of indirect methods of estimating MI 
size	such	as	echocardiography,	electrocardiography,	and	biomarkers.	In	the	studies	
for this thesis, DE-CMR was the golden standard for determining segmental infarct 
transmurality	and	global	MI	size.	DE-CMR	has	proved	very	sensitive	and	specific	
in quantifying infarct scar, capable of detecting even very small infarct lesions of 
1	gram	(Wu	et	al.	2001a).	Transmural	extent	of	infarct	correlates	with	myocardial	
contraction, and predicts recovery of ischemic, dysfunctional myocardium with 
revascularization:	Contraction	in	segments	with	infarct	transmurality	>	75%	does	
not recover, whereas the probability of recovery is possible with less severe infarct 
damage, and most probable if the infarct transmurality is < 25% (Choi et al. 2001, 
Gerber et al. 2002).
In	Study	IV,	infarction	injury	was	also	assessed	by	peak	CK-MBm	release.	CK-
MBm	reflects	the	size	of	the	ischemic	region	at	risk.	After	timely	reperfusion,	CK-
MBm	release	is	higher	and	more	rapid,	and	it	reflects	the	amount	of	myocardium	
salvaged in addition to the amount of myocardium lost (Ong et al. 1983, Tamaki et 
al. 1983, Hedstrom et al. 2007). In Study IV, the timing of CK-BMm measurements 
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was	not	strictly	prespecified	with	regards	to	the	onset	of	chest	pain	or	reperfusion;	
even so, the routine measurements yielded a good correlation between peak CK-
MBm	and	final	infarction	percentage,	r	=	0.65,	which	falls	within	the	range	seen	
in other studies.
6.2.2 Echocardiographic assessment of infarct size and myocardial viability
Myocardial contraction has been assessed by echocardiography since the 1970’s. 
Experimental,	as	well	as	clinical	autopsy-	and	DE-CMR	studies	have	shown	that	the	
extent	and	severity	of	contraction	abnormality	by	two-dimensional	echocardiography	
strongly	 correlates	with	 segmental	 and	global	LV	 infarct	 size	during	and	after	
infarction	healing	(Weiss	et	al.	1981,	Shen	et	al.	1991,	Gjesdal	et	al.	2008,	Sjoli	et	
al. 2009). In the acute phase of infarction, infarct-related contraction abnormalities 
appear alongside contraction abnormalities that are due to potentially reversible 
causes, such as acute ischemia, stunning, and hibernation. Thus, contraction 
abnormalities	in	the	early	acute	phase	may	overestimate	MI	size	(Wyatt	et	al.	1981,	
Nieminen et al. 1982). Recovery of segmental contraction abnormalities after acute 
MI	is	determined	by	transmural	extent	of	MI.	Segments	with	a	transmural	extent	
< 50% most probably recover. In patients with prior MI, all segments with visible 
contraction within the weeks before death had subendocardial, or no infarction at 
autopsy (Weiss et al. 1981, Shen et al. 1991). In chronic MI, such non-transmural 
infarcts may go unnoticed, as the segments may be normokinetic (Mahrholdt et 
al. 2003). Early after thrombolysis, and later, visual WMS was able to differentiate 
between	transmural	and	non-transmural	infarctions.	In	chronic	MI,	the	WMS	index	
and	EF	could	separate	large	infarctions	from	medium-sized	ones,	but	not	medium	
from	small	infarctions	(Gjesdal	et	al.	2008,	Sjoli	et	al.	2009,	Thorstensen	et	al.	2012).
MI size and extent by strain rate imaging
Strain- and strain rate imaging has previously been validated mostly for detection 
of acute ischemia and presence of an infarct. Studies I and II showed that estimates 
of	transmural	extent	of	MI,	as	well	as	global	MI	size,	are	also	possible	by	strain	
rate	 imaging.	In	acute	MI,	the	correlation	with	final	MI	size	was	 less	close	than	
in	chronic	MI,	a	finding	which	could	be	expected.	The	correlation	between	global	
strain and infarct percentage in chronic MI (r = 0.74) was equal to that in one study 
(Sachdev et al. 2006), but lower in acute MI (r = 0.54) than also reported (Vartdal et 
al. 2007). In chronic MI, segmental systolic strain values decreased with increasing 
extent	of	infarct	transmurality.	These	findings	are	concordant	with	experimental	and	
clinical studies showing a similar association between systolic strain- and strain-
rate	values	and	transmurality	(Derumeaux	et	al.	2001,	Weidemann	et	al.	2003,	
Zhang et al. 2005, Weidemann et al. 2006b, Vartdal et al. 2007). In accordance 
with these studies, systolic strain values could differentiate between segments with 
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transmural infarct and those with non-transmural or no infarct, but systolic strain 
values could not differ segments without infarct from those with non-transmural 
infarct.	This	was	in	contrast	to	findings	further	suggesting	strain	rate	imaging	to	
be more sensitive than WMS in this regard (Zhang et al. 2005, Weidemann et al. 
2006b, Vartdal et al. 2007).
Viability by strain rate imaging in acute MI
In acute MI, recovery of contraction in acutely non-contractile segments was 
predictable by strain- and strain-rate values (Study II). Interestingly, post-systolic 
strain	had	the	highest	predictive	accuracy.	In	experimental	studies,	post-systolic	
strain has been a marker of viability and active contraction, present in myocardial 
segments with < 70% infarct transmurality. The absence of post-systolic strain is due 
to decreased tissue compliance in transmurally infarcted myocardium (Pislaru et al. 
2004a, Lyseggen et al. 2005, Skulstad et al. 2006b). Viability has not been earlier 
assessed in a way similar to that in our Study II, but our results receive support from 
clinical studies showing that soon after reperfusion for acute MI, systolic strain- and 
strain-rate variables can distinguish segments without transmural infarct, these 
being presumably viable (Zhang et al. 2005, Weidemann et al. 2006b, Vartdal 
et al. 2007). Our Study II results were recently reproduced in a study using two-
dimensional speckle-tracking echocardiography1; in patients with acute MI, systolic 
strain, systolic strain rate, and post-systolic strain each predicted recovery of severely 
dysfunctional segments (Park et al. 2013). Other recent speckle-tracking studies, 
as well, have shown an association between strain variables and viability (Lipiec et 
al. 2011, Cimino et al. 2013, Altiok et al. 2014, Rost et al. 2014).
6.2.3 Electrocardiographic assessment of MI size and viability
Recommendations for diagnosis of MI based on QRS-, ST-, and T-wave changes in 
the	conventional	12-lead	ECG	appeared	in	the	first	WHO	report	on	the	definition	
of MI in 1959 (Groen et al.). BSPM studies in the 1970’s and later have found that 
recording ECG outside the standard 12 leads improves the diagnostic accuracy 
for	MI	(Menown	et	al.	2001,	Vesterinen	2007).	The	extent	and	magnitude	of	ST	
elevation and of Q-, and R waves on the thoracic surface have correlated with MI 
location	and	MI	size.	Especially	departure	maps,	displaying	the	location	and	extent	of	
pathologic	values	exceeding	normal	values	by	2	SD,	have	shown	strong	correlations	
with	MI	size.	In	those	studies,	the	computed	QRS-	and	QRST	integrals	performed	
even better than did the Q wave (Tonooka et al. 1983b, Kubota et al. 1985, Hayashi 
1 Speckle-tracking echocardiography measures myocardial strain and strain rate by tracking acoustic markers 
in the myocardium.
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et al. 1993). Recent studies have found computed BSPM variables to outperform 
the Q wave in diagnosis of prior MI, irrespective of MI location (Vesterinen et al. 
2008a,	2008b).	Studies	III	and	IV	were,	to	our	knowledge,	the	first	to	report	on	the	
performance of a variety of computed single-lead BSPM variables in assessment of 
MI	size	at	different	stages	of	infarction,	and	in	prediction	of	recovery	of	LV	function	
in patients with acute MI.
Depolarization variables
The	classical	Q	wave	(width	≥	20–30	ms	and	depth	≥	1	mm)	in	standard	12-lead	
ECG is clinically the most important marker of infarct scar, and interestingly, the 
computed Q wave showed itself to be the best BSPM variable of all in assessment 
of	MI	size	and	viability.	The	computed	Q	wave	was	already	strongly	correlated	with	
MI	size	within	48	hours	of	the	acute	event;	these	correlations	grew	even	stronger	
during the healing phase, and were strongest after complete infarction healing. The 
slightly stronger correlations noted after the acute phase may have been connected 
with Q waves appearing later in some patients (Kleiger et al. 1990). Acute Q waves 
can	also	result	 from	electrocardiographic	stunning,	and	may	not	always	reflect	
irreversible damage (Birnbaum & Ware 2005, Isobe et al. 2006).
In patients with acute MI, the 1st QRSint predicted recovery from LAD- and 
RCA-related dysfunction with good accuracy, although the proportion of patients 
with clinical QMI in the recovery and the non-recovery groups did not differ. Other 
studies	also	have	indicated	that	Q	waves	do	not	necessarily	exclude	viability,	as	Q	
waves	are	more	closely	related	to	total	MI	size	and	extent	of	subendocardial	MI	
than they are to the segmental transmurality of MI (Moon et al. 2004, Kaandorp 
et al. 2005, Engblom et al. 2007). Recovery of LV dysfunction after thrombolysis 
was, however, greater in the absence of Q waves (Isselbacher et al. 1996, Lancellotti 
et al. 2001). That the 1st QRSint would perform better than the clinical Q wave 
may be due to the computed Q wave’s being more sensitive, and also be because 
the best recording site for assessing viability in RCA territory was on the upper 
sternum, clearly outside the standard ECG leads. The 4th QRSint was better than 
the 1st QRSint at predicting recovery from LCX-related LV dysfunction. This is in 
accordance	with	the	finding	that	posterolateral	MIs	cause	changes	in	the	terminal	
part of the QRS (Pahlm et al. 1998).
In addition to the computed Q wave, the computed R wave and the QRSint also 
showed	strong	correlations	with	final	MI	size	at	all	stages	of	the	infarction,	from	
acute to chronic. Correlations of the computed QRS variables were of a magnitude 
similar to magnitudes observed for the Selvester QRS score, the best-validated ECG 
score	for	assessing	MI	size.	The	computed	QRS	variables	already	performed	well	
in the acute phase, while the Selvester QRS score has been validated mainly in the 
subacute phase and later (Engblom et al. 2005a, Geerse et al. 2009, Welinder et al. 
2009, Knippenberg et al. 2010, Carlsen et al. 2012). Correlation of Selvester QRS 
score	with	MI	size	varied	with	MI	location,	being	highest	in	anterior	MI,	and	lowest	
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in multiple MI (Pahlm et al. 1998, De Sutter et al. 1999, Engblom et al. 2005a). 
In	contrast,	computed	QRS	variables	reflected	MI	size	in	an	unselected	group	of	
patients with differing MI locations, the best recording sites being on the left side 
around standard leads V3 to V6, and on the right upper back. This may indicate 
that	computed	QRS	variables	can	assess	MI	size	irrespective	of	MI	location	from	
these two sites. However, on the basis of these results, it is impossible to say how 
the computed QRS variables perform with regards to individual MI locations.
Repolarization variables
In	acute	MI,	the	repolarization	variables	predicted	recovery	of	LV	dysfunction	with	
good accuracy, irrespective of MI location. Studies have found that the greater 
the	maximal	residual	ST	deviation	(elevation	or	depression)	1	 to	24	hours	after	
reperfusion	for	STEMI,	the	larger	the	MI	size,	the	smaller	the	EF,	and	the	worse	
the prognosis (McLaughlin et al. 2004, Brodie et al. 2005, De Luca et al. 2008, 
Hallen et al. 2010). Residual ST elevation indicates severe microvascular damage, 
associated	with	adverse	LV	remodeling	(Nijveldt	et	al.	2009,	Weaver	et	al.	2011).	
In NSTEMI, deeper ST depression implies worse prognosis (Schechtman et al. 
1989, Cannon et al. 1997, Kaul et al. 2001, Savonitto et al. 2005, Yan et al. 2010). 
After reperfusion for STEMI, negative T waves indicate successful reperfusion and 
smaller	MI	size;	positive	T	waves	remaining	high	are	associated	with	 larger	MI	
size	and	smaller	EF	(Matetzky	et	al.	1994,	Corbalan	et	al.	1999,	Sorensen	et	al.	
2009). In accordance with those observations, in our Study III, the ST segment 
was lower and the T wave smaller in patients with recovery from LAD-related LV 
dysfunction than in patients without. However, the best recording site was on the 
left upper back, showing negative STT values in both patient groups, equal to those 
in healthy controls.
Despite their good performance in assessing viability, the acute-phase 
repolarization	variables	showed	only	weak	or	moderate	correlations	with	final	MI	
size.	Correlations	with	T-wave	variables	improved	with	time,	whereas	correlations	
with ST-segment variables remained weak. Others’ studies have shown that after 
the acute event, patients with a larger MI have T waves remaining low or negative, 
whereas in patients with a small MI, during recovery, negative T waves turn positive, 
and positive T waves increase in amplitude. In chronic MI, a negative T wave 
indicates transmural infarct (Maeda et al. 1996, Bosimini et al. 2000, Sakata et al. 
2001, Lancellotti et al. 2002). However, in most patients, the ST segment gradually 
returns	to	normal.	In	Study	IV,	 the	poor	correlation	of	repolarization	variables	
with	MI	size	acutely	may	be	due	to	pooling	patients	with	multiple	MI	locations.	
An	additional	explanation	is	the	dynamic	nature	of	repolarization	variables	in	the	
early acute phase, because the timing of measurement could differ by 24 hours. 
QRS variables are more stable throughout the infarction process, and probably 
therefore	performed	better	than	the	repolarization	variables.
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6.3 Clinical implications
In	patients	with	acute	and	chronic	MI,	infarct	scar	size	correlates	with	LV	function,	
and is an important prognostic marker. Patients with a large MI are at risk for 
developing severe arrhythmias and heart failure, and need to be closely followed 
up	to	optimize	therapy.	In	patients	with	dysfunctional	myocardium	after	infarction,	
viability	assessment	may	help	in	deciding	upon	the	need	for	revascularization.
This thesis shows that in acute as well as chronic MI, strain rate imaging 
and	BSPM	can	be	helpful	 in	assessing	MI	size	and	myocardial	viability.	These	
echocardiographic and electrocardiographic techniques are easily available and 
possible	to	perform	at	bedside	at	any	time.	Validated	imaging	methods	for	defining	
the	extent	of	infarct	scar,	ones	such	as	DE-CMR,	are	not	widely	available	and	in	
general, in acute cases cannot be performed.
Strain rate imaging measures regional myocardial contraction. In comparison 
with traditional wall-motion assessment by echocardiography, strain rate imaging 
is	objective,	quantitative,	and	more	sensitive.	Contraction	abnormalities	are	not	
always easy to discern by eye, but strain rate imaging can help determine the degree 
of abnormal contraction. Strain rate imaging was feasible and reproducible also in 
the studies for this thesis. Here, strain mapping was validated as a semi-quantitative 
method for estimating myocardial systolic strain. Strain mapping can quickly scan 
for contraction abnormalities. In patients with chronic MI, severely reduced systolic 
strain found by strain mapping can identify segments with transmural infarct, similar 
to quantitative strain. Segments with normal, or only slightly impaired strain, are 
viable, and most probably have no infarct, or a non-transmural one. In acute MI, 
strain rate imaging can discern viable myocardium and predict functional recovery 
of non-contracting segments. In both acute and chronic MI, global systolic strain 
correlates	with	global	MI	size.	This	study	shows	that	strain	rate	imaging	is	possible	
in most of the segments (80%), even though poor visibility is a problem, as it is for 
echocardiography in general.
The BSPM studies for this thesis show that automatically computed ECG 
variables	can	estimate	MI	size	at	all	stages	of	MI:	in	acute	MI	after	reperfusion,	as	
well as during and after healing of the infarction. In patients with acute MI, computed 
ECG variables can predict functional recovery of the LV. The BSPM studies found 
that	MI	size	 is	best	assessed	from	the	region	around	standard	ECG	leads	V3	to	
V5, and the right upper back. The optimal site for assessing myocardial viability 
depends on the region of LV dysfunction: Recovery from LAD- and LCX-related 
LV dysfunction is best assessed from the region around standard leads V4 to V6, 
whereas recovery from RCA-related LV dysfunction should be assessed from the 
upper	sternum	or	the	right	upper	back.	Thus,	assessment	of	MI	size	and	viability	
is possible by placing only a few supplementary ECG leads outside the standard 
chest leads, and would be feasible even in clinical practice.
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Both strain rate imaging and computed analysis of electrocardiograpy seem to be 
promising tools to aid the clinician in assessing the degree of permanent infarction 
damage in patients with MI.
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1. Regional myocardial systolic strain can be estimated in a semi-quantitative manner 
from color-coded two-dimensional images by tissue Doppler imaging, a method 
we call strain mapping.
2.	Systolic	strain	can	assess	segmental	and	global	infarct	size.	Systolic	strain	values	
obtained	quantitatively,	or	by	 strain	mapping,	 reflect	 the	 transmural	extent	of	
segmental infarct scar in chronic MI, and can differentiate transmural from non-
transmural	MI.	Global	systolic	strain	shows	good	correlation	with	global	MI	size	
in chronic as well as in acute MI.
3. Strain rate imaging can predict recovery of segmental and global LV dysfunction 
in	acute	MI.	Acutely	measured	strain-	and	strain-rate	values	correlate	with	final	
segmental and global strain after healing of the infarction, and can differentiate 
between viable and non-viable non-contractile segments. Systolic and post-systolic 
strain, and systolic strain rate perform the best.
4. Computed ECG variables by BSPM in acute MI can predict recovery of LV 
dysfunction.	Repolarization	variables	perform	well	irrespective	of	MI	location.	Only	
in LAD-related MI is the 1st QRSint the best variable of all. The best recording location 
for predicting LAD- and LCX-associated LV dysfunction was around standard ECG 
leads V4 to V6. For predicting RCA-associated LV dysfunction, the best recording 
location was on the upper sternum and the right upper back, outside the standard 
chest leads.
5.	BSPM	can	estimate	MI	size	at	all	stages	of	the	infarction.	Depolarization-	as	well	
as	repolarization	variables	computed	by	BSPM	show	good	correlations	with	MI	size	
in	chronic	MI.	Depolarization	variables	perform	well	even	in	the	acute	phase	of	MI;	
repolarization	variables	do	not.	Both	depolarization-	and	repolarization	variables	
show	good	correlations	with	final	MI	size	in	the	healing	phase	of	infarction.	At	all	
time-points, Q- and R-wave variables, and QRSint, perform best of all. Q-wave 
variables	showed	their	highest	correlations	with	MI	size	on	the	right	upper	back;	
the R-wave variables and the QRSint performed the best around standard ECG 
leads V3 to V5.
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